Crl:CD(SD) |
plasma alanine aminotransferase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood alanine transaminase amount |
male |
133 days
| 19 |
|
|
32.4 |
U/l |
0.99 |
4.3 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85437 |
1604 |
Crl:CD(SD) |
food intake rate |
standard diet then acetaminophen (300 mg/kg) (for 56 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
126 days
| 8 |
|
|
24.6 |
g/d |
0.21 |
0.6 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85471 |
1604 |
Crl:CD(SD) |
food intake weight to body weight ratio |
standard diet and restricted feeding (4 h) then acetaminophen (500 mg/kg) (for 14 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
84 days
| 8 |
|
|
6.04 |
g/d/100g |
0.23 |
0.66 |
unspecified method |
|
0.0 |
|
0 |
|
|
on days 11-14 |
85493 |
1604 |
Crl:CD(SD) |
food intake weight to body weight ratio |
standard diet and restricted feeding (4 h) then acetaminophen (300 mg/kg) (for 98 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
168 days
| 8 |
|
|
3.96 |
g/d/100g |
0.35 |
0.98 |
unspecified method |
|
0.0 |
|
0 |
|
|
on days 95-98 |
85516 |
1604 |
Crl:CD(SD) |
body weight |
standard diet then acetaminophen (500 mg/kg) (for 35 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
105 days
| 8 |
|
|
472.0 |
g |
8.49 |
24.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85532 |
1604 |
Crl:CD(SD) |
food intake weight to body weight ratio |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
84 days
| 19 |
|
|
5.78 |
g/d/100g |
0.1 |
0.42 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85300 |
1604 |
Crl:CD(SD) |
food intake weight to body weight ratio |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
126 days
| 19 |
|
|
4.74 |
g/d/100g |
0.11 |
0.5 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85304 |
1604 |
Crl:CD(SD) |
body weight |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
147 days
| 19 |
|
|
563.0 |
g |
13.54 |
59.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85318 |
1604 |
Crl:CD(SD) |
body weight |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
105 days
| 19 |
|
|
374.0 |
g |
5.28 |
23.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85315 |
1604 |
Crl:CD(SD) |
plasma glucose level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glucose amount |
male |
78 days
| 19 |
|
|
130.0 |
mg/dl |
1.84 |
8.0 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85324 |
1604 |
Crl:CD(SD) |
plasma glucose level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glucose amount |
male |
147 days
| 19 |
|
|
129.0 |
mg/dl |
0.92 |
4.0 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85334 |
1604 |
Crl:CD(SD) |
plasma lactate level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood lactate amount |
male |
70 days
| 19 |
|
|
14.7 |
mg/dl |
1.1 |
4.8 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85355 |
1604 |
Crl:CD(SD) |
plasma lactate level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood lactate amount |
male |
78 days
| 19 |
|
|
21.1 |
mg/dl |
1.08 |
4.7 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85356 |
1604 |
Crl:CD(SD) |
plasma lactate level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood lactate amount |
male |
147 days
| 19 |
|
|
17.0 |
mg/dl |
1.24 |
5.4 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85366 |
1604 |
Crl:CD(SD) |
plasma lactate level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood lactate amount |
male |
133 days
| 19 |
|
|
30.2 |
mg/dl |
2.87 |
12.5 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85365 |
1604 |
Crl:CD(SD) |
urine taurine excretion rate |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
urine taurine amount |
male |
70 days
| 19 |
|
|
68.7 |
umol/d |
8.69 |
37.9 |
liquid chromatography-mass spectrometry |
|
0.0 |
|
0 |
|
|
|
85394 |
1604 |
Crl:CD(SD) |
plasma aspartate aminotransferase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood aspartate transaminase amount |
male |
70 days
| 19 |
|
|
60.7 |
U/l |
1.19 |
5.2 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85410 |
1604 |
Crl:CD(SD) |
plasma alanine aminotransferase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood alanine transaminase amount |
male |
91 days
| 19 |
|
|
35.4 |
U/l |
1.49 |
6.5 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85431 |
1604 |
Crl:CD(SD) |
plasma glutamate dehydrogenase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glutamate dehydrogenase amount |
male |
78 days
| 19 |
|
|
13.7 |
U/l |
0.48 |
2.1 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85444 |
1604 |
Crl:CD(SD) |
plasma glutamate dehydrogenase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glutamate dehydrogenase amount |
male |
91 days
| 19 |
|
|
15.5 |
U/l |
0.62 |
2.7 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85447 |
1604 |
Crl:CD(SD) |
food intake rate |
standard diet and restricted feeding (4 h) then acetaminophen (300 mg/kg) (for 14 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
84 days
| 8 |
|
|
20.3 |
g/d |
1.06 |
3.0 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85462 |
1604 |
Crl:CD(SD) |
food intake rate |
standard diet and restricted feeding (4 h) then acetaminophen (500 mg/kg) (for 14 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
84 days
| 8 |
|
|
18.8 |
g/d |
0.92 |
2.6 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85463 |
1604 |
Crl:CD(SD) |
food intake rate |
standard diet and restricted feeding (4 h) then acetaminophen (300 mg/kg) (for 98 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
168 days
| 8 |
|
|
18.3 |
g/d |
1.98 |
5.6 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85486 |
1604 |
Crl:CD(SD) |
food intake weight to body weight ratio |
standard diet then acetaminophen (500 mg/kg) (for 14 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
84 days
| 8 |
|
|
5.68 |
g/d/100g |
0.06 |
0.17 |
unspecified method |
|
0.0 |
|
0 |
|
|
on days 11-14 |
85490 |
1604 |
Crl:CD(SD) |
food intake weight to body weight ratio |
standard diet then acetaminophen (500 mg/kg) (for 35 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
105 days
| 8 |
|
|
5.12 |
g/d/100g |
0.15 |
0.42 |
unspecified method |
|
0.0 |
|
0 |
|
|
on days 32-35 |
85496 |
1604 |
Crl:CD(SD) |
food intake weight to body weight ratio |
standard diet and restricted feeding (4 h) then acetaminophen (300 mg/kg) (for 35 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
105 days
| 8 |
|
|
5.09 |
g/d/100g |
0.24 |
0.67 |
unspecified method |
|
0.0 |
|
0 |
|
|
on days 32-35 |
85498 |
1604 |
Crl:CD(SD) |
body weight |
standard diet and restricted feeding (4 h) then acetaminophen (300 mg/kg) (for 35 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
105 days
| 8 |
|
|
375.0 |
g |
12.73 |
36.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85534 |
1604 |
Crl:CD(SD) |
plasma acetaminophen level area under curve |
standard diet and restricted feeding (4 h) (for 114 days) then acetaminophen (300 mg/kg) (for 99 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood acetaminophen amount |
male |
170 days
| 8 |
|
|
373.9 |
(ug/ml) x h |
38.93 |
110.1 |
high-performance liquid chromatography |
|
0.0 |
acetaminophen dosing |
1140 |
min |
4-19 hr dosing |
4-19 hr dosing |
85588 |
1604 |
Crl:CD(SD) |
plasma glucose level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glucose amount |
male |
70 days
| 19 |
|
|
143.0 |
mg/dl |
1.38 |
6.0 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85322 |
1604 |
Crl:CD(SD) |
urine creatinine excretion rate |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
urine creatinine amount |
male |
70 days
| 19 |
|
|
7.64 |
mg/d |
0.27 |
1.17 |
liquid chromatography-mass spectrometry |
|
0.0 |
|
0 |
|
|
|
85387 |
1604 |
Crl:CD(SD) |
food intake weight to body weight ratio |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
168 days
| 19 |
|
|
4.01 |
g/d/100g |
0.27 |
1.17 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85309 |
1604 |
Crl:CD(SD) |
body weight |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
84 days
| 19 |
|
|
419.0 |
g |
8.72 |
38.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85312 |
1604 |
Crl:CD(SD) |
urine creatine excretion rate |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
urine creatine amount |
male |
134 days
| 19 |
|
|
2.44 |
umol/d |
0.08 |
0.37 |
liquid chromatography-mass spectrometry |
|
0.0 |
|
0 |
|
|
|
85382 |
1604 |
Crl:CD(SD) |
urine taurine excretion rate |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
urine taurine amount |
male |
169 days
| 19 |
|
|
153.1 |
umol/d |
7.75 |
33.8 |
liquid chromatography-mass spectrometry |
|
0.0 |
|
0 |
|
|
|
85401 |
1604 |
Crl:CD(SD) |
food intake weight to body weight ratio |
standard diet then acetaminophen (500 mg/kg) (for 98 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
168 days
| 8 |
|
|
4.24 |
g/d/100g |
0.06 |
0.18 |
unspecified method |
|
0.0 |
|
0 |
|
|
on days 95-98 |
85514 |
1604 |
Crl:CD(SD) |
plasma glutamate dehydrogenase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glutamate dehydrogenase amount |
male |
105 days
| 19 |
|
|
13.5 |
U/l |
0.21 |
0.9 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85449 |
1604 |
Crl:CD(SD) |
food intake rate |
standard diet then acetaminophen (500 mg/kg) (for 56 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
126 days
| 8 |
|
|
24.9 |
g/d |
0.85 |
2.4 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85472 |
1604 |
Jcl:WI |
heart left ventricle weight to body weight ratio |
standard diet |
Radosinska J, et al., Physiol Res. 2015;64(6):795-806. Epub 2015 Oct 8. |
heart left ventricle mass |
male |
84 days
| 8 |
|
|
1.85 |
mg/g |
0.03 |
0.09 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
103067 |
2785 |
GK/Jcl |
heart left ventricle weight to body weight ratio |
standard diet |
Radosinska J, et al., Physiol Res. 2015;64(6):795-806. Epub 2015 Oct 8. |
heart left ventricle mass |
male |
84 days
| 8 |
|
|
1.95 |
mg/g |
0.01 |
0.03 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
103069 |
2785 |
SR/Hsd |
mean arterial blood pressure |
standard diet |
Wu F, et al., Int J Hypertens. 2016;2016:9146870. doi: 10.1155/2016/9146870. Epub 2016 Dec 19. |
arterial blood pressure trait |
male |
49 days
| 8 |
|
|
120.0 |
mmHg |
1.06 |
3.0 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
102267 |
2683 |
WKY |
blood very low density lipoprotein triglyceride level |
standard diet (for 20 days) |
Orolin J, et al., Food Chem Toxicol. 2009 Oct;47(10):2624-30. doi: 10.1016/j.fct.2009.07.022. Epub 2009 Jul 25. |
blood VLDL triglyceride amount |
male |
0 days
| 7 |
|
|
0.96 |
mg/dl |
0.2 |
0.53 |
enzymatic triglyceride assay |
|
0.0 |
|
0 |
|
|
|
98922 |
2178 |
SR/Hsd |
plasma urotensin II level |
standard diet |
Wu F, et al., Int J Hypertens. 2016;2016:9146870. doi: 10.1155/2016/9146870. Epub 2016 Dec 19. |
blood urotensin II amount |
male |
49 days
| 8 |
|
|
61.0 |
pg/ml |
2.09 |
5.9 |
radioimmunoassay |
|
0.0 |
|
0 |
|
|
|
102275 |
2683 |
SR/Hsd |
urine sodium level |
standard diet |
Wu F, et al., Int J Hypertens. 2016;2016:9146870. doi: 10.1155/2016/9146870. Epub 2016 Dec 19. |
urine sodium amount |
male |
49 days
| 8 |
|
|
0.3 |
mmol/l |
0.04 |
0.1 |
urine sodium analysis |
|
0.0 |
|
0 |
|
|
|
102281 |
2683 |
SS |
creatinine clearance |
standard diet |
Wu F, et al., Int J Hypertens. 2016;2016:9146870. doi: 10.1155/2016/9146870. Epub 2016 Dec 19. |
glomerular filtration trait |
male |
49 days
| 8 |
|
|
4.2 |
ml/min |
0.25 |
0.7 |
urine creatinine analysis |
|
0.0 |
|
0 |
|
|
|
102286 |
2683 |
WI |
systolic blood pressure |
controlled in utero environment (for 21 days) and standard diet (100 % of calories) (for 21 days) |
Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10. |
arterial blood pressure trait |
male |
102 days
| 21 |
mean of 3 samples of undefined duration |
serial mean |
119.0 |
mmHg |
0.75 |
3.44 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
101055 |
2563 |
SHR/N-cp |
serum glucose level |
standard diet (between 28 and 42 days) then controlled carbohydrate content diet (54 %) (between 112 and 126 days) |
Velasquez MT, et al., Hypertension. 1997 Nov;30(5):1232-7. |
blood glucose amount |
male |
140 days-168 days |
8 |
|
|
145.2 |
mg/dl |
23.6 |
66.74 |
serum glucose analysis |
|
0.0 |
|
0 |
|
|
|
101505 |
2601 |
WI |
plasma triglyceride level |
controlled in utero environment (for 21 days) and standard diet (100 % of calories) (for 21 days) |
Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10. |
blood triglyceride amount |
male |
102 days
| 6 |
|
|
0.62 |
mmol/l |
0.08 |
0.2 |
plasma triglyceride analysis |
|
0.0 |
|
0 |
|
|
|
101069 |
2563 |
WI |
plasma total cholesterol level |
controlled in utero environment (for 21 days) and standard diet (100 % of calories) (for 21 days) |
Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10. |
blood cholesterol amount |
male |
102 days
| 6 |
|
|
38.83 |
mg/dl |
3.19 |
7.81 |
plasma total cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
101071 |
2563 |
SD-Abcc6em2Qlju+/- |
serum phosphate level |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood phosphate amount |
female |
60 days-180 days |
5 |
|
|
5.7 |
mg/dl |
0.1 |
0.22 |
liquid phase colorimetry |
|
0.0 |
|
0 |
|
|
|
104645 |
2972 |
SD-Abcc6em2Qlju+/- |
serum calcium to serum phosphate ratio |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood calcium amount |
male |
60 days-180 days |
5 |
|
|
1.44 |
null |
0.08 |
0.18 |
colorimetry |
|
0.0 |
|
0 |
|
|
|
104650 |
2972 |
SD-Abcc6em2Qlju-/- |
plasma pyrophosphate level |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood pyrophosphate amount |
female |
60 days-180 days |
5 |
|
|
0.24 |
umol/l |
0.05 |
0.11 |
enzymatic method |
|
0.0 |
|
0 |
|
|
|
104659 |
2972 |
SD-Abcc6em2Qlju-/- |
serum phosphate level to plasma pyrophosphate level ratio |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood pyrophosphate amount |
male |
60 days-180 days |
5 |
|
|
2082.3 |
null |
626.9 |
1401.79 |
liquid phase colorimetry |
|
0.0 |
|
0 |
|
|
|
104664 |
2972 |
MHS |
timed urine volume |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
urine output |
male |
63 days
| 10 |
|
|
14.0 |
ml/d |
0.97 |
3.08 |
urine volume measurement method |
|
0.0 |
|
0 |
|
|
|
104169 |
2927 |
MHS |
timed urine volume |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
urine output |
male |
270 days
| 10 |
|
|
15.2 |
ml/d |
1.23 |
3.9 |
urine volume measurement method |
|
0.0 |
|
0 |
|
|
|
104172 |
2927 |
MNS |
serum creatinine level |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
blood creatinine amount |
male |
63 days
| 10 |
|
|
0.31 |
mg/dl |
0.01 |
0.02 |
creatinine analysis by Jaffe reaction with spectrophotometric readout |
|
0.0 |
|
0 |
|
|
|
104174 |
2927 |
Crl:WI |
serum creatinine level |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
blood creatinine amount |
male |
63 days
| 10 |
|
|
0.39 |
mg/dl |
0.01 |
0.03 |
creatinine analysis by Jaffe reaction with spectrophotometric readout |
|
0.0 |
|
0 |
|
|
|
104179 |
2927 |
MNS |
urine total protein excretion rate |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
total urine protein amount |
male |
270 days
| 10 |
|
|
604.98 |
mg/d |
50.69 |
160.29 |
urine protein analysis |
|
0.0 |
|
0 |
|
|
|
104189 |
2927 |
MHS |
urine total protein excretion rate |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
total urine protein amount |
male |
270 days
| 10 |
|
|
19.78 |
mg/d |
1.92 |
6.07 |
urine protein analysis |
|
0.0 |
|
0 |
|
|
|
104190 |
2927 |
MNS |
body weight |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
body mass |
male |
63 days
| 10 |
|
|
270.8 |
g |
4.3 |
13.6 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
104192 |
2927 |
MHS |
left kidney wet weight |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
kidney mass |
male |
63 days
| 10 |
|
|
0.76 |
g |
0.01 |
0.02 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
104199 |
2927 |
MHS |
artery diameter |
standard diet (for 63 days) |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
kidney blood vessel morphology trait |
male |
63 days
| 10 |
|
|
34.3 |
um |
0.85 |
2.7 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
0 |
|
|
|
104211 |
2927 |
MWF/Ztm |
urine total protein excretion rate |
standard diet |
Remuzzi A, etal., Kidney Int. 1988 Oct;34(4):481-6. doi: 10.1038/ki.1988.206. |
urine protein amount |
female |
147 days
| 5 |
|
|
25.0 |
mg/d |
5.81 |
13.0 |
Bradford protein assay |
|
0.0 |
|
0 |
|
|
|
109202 |
3138 |
MWF/Ztm |
total filtering surface area per glomerulus |
standard diet |
Iordache BE, etal., J Am Soc Nephrol. 1994 Dec;5(6):1378-84. |
kidney glomerulus morphology trait |
male |
252 days-253 days |
5 |
NA |
|
0.34 |
mm2 |
0.02 |
0.04 |
ex vivo electron microscopy with digital image analysis |
renal glomerulus |
0.0 |
|
0 |
|
|
|
109165 |
3136 |
MWF/Ztm |
mean length density of glomerular capillaries |
standard diet |
Iordache BE, etal., J Am Soc Nephrol. 1994 Dec;5(6):1378-84. |
glomerular capillary morphology trait |
male |
252 days-253 days |
5 |
2xNcap/k2xPr, Ncap is number of capillary profiles, k2 is ratio between the distance (In micrometers) of two adjacent grid points and the magnification, Pr is grid points falling Into the glomerular tuft |
|
13.0 |
REQUEST NEW VALUE |
1.3 |
2.9 |
ex vivo electron microscopy with digital image analysis |
renal glomerulus |
0.0 |
|
0 |
|
|
|
109178 |
3136 |
MWF/Fub |
body weight |
standard diet |
Kreutz R, etal., J Hypertens. 2000 Jun;18(6):777-82. doi: 10.1097/00004872-200018060-00017. |
body mass |
male |
104 days
| 8 |
|
|
319.0 |
g |
7.1 |
20.08 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
109001 |
3134 |
LEW/Mol |
kidney wet weight to body weight ratio |
standard diet |
Kreutz R, etal., J Hypertens. 2000 Jun;18(6):777-82. doi: 10.1097/00004872-200018060-00017. |
kidney mass |
female |
104 days
| 8 |
|
|
3.74 |
mg/g |
0.09 |
0.25 |
post excision weight measurement |
kidney |
0.0 |
|
0 |
|
|
|
109012 |
3134 |
MWF/Ztm |
urine total protein excretion rate |
standard diet |
Remuzzi A, etal., Am J Kidney Dis. 1999 Oct;34(4):626-32. doi: 10.1016/S0272-6386(99)70385-9. |
total urine protein amount |
male |
210 days
| 10 |
|
|
325.0 |
mg/d |
27.2 |
86.0 |
Bradford protein assay |
|
0.0 |
|
0 |
|
|
|
109981 |
3162 |
SHRSP/A3NCrl |
partial pressure of brain white matter oxygen |
standard diet |
Weaver J, etal., J Cereb Blood Flow Metab. 2014 May;34(5):890-6. doi: 10.1038/jcbfm.2014.35. Epub 2014 Feb 19. |
brain oxygen amount |
male |
112 days
| 6 |
|
|
25.6 |
mmHg |
1.2 |
2.94 |
electron paramagnetic resonance oximetry |
white matter |
40.0 |
|
0 |
|
5 scans x 40 seconds |
vascular cognitive impairment |
107318 |
3080 |
LEW/Mol |
body weight |
standard diet |
Kreutz R, etal., J Hypertens. 2000 Jun;18(6):777-82. doi: 10.1097/00004872-200018060-00017. |
body mass |
female |
104 days
| 8 |
|
|
193.0 |
g |
2.6 |
7.35 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
108996 |
3134 |
MWF/Fub |
body weight |
standard diet |
Kreutz R, etal., J Hypertens. 2000 Jun;18(6):777-82. doi: 10.1097/00004872-200018060-00017. |
body mass |
female |
104 days
| 8 |
|
|
193.0 |
g |
2.8 |
7.92 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
109000 |
3134 |
MWF/Fub |
kidney wet weight to body weight ratio |
standard diet |
Kreutz R, etal., J Hypertens. 2000 Jun;18(6):777-82. doi: 10.1097/00004872-200018060-00017. |
kidney mass |
male |
104 days
| 8 |
|
|
2.87 |
mg/g |
0.05 |
0.14 |
post excision weight measurement |
kidney |
0.0 |
|
0 |
|
|
|
109017 |
3134 |
SD-Ldlrem1Sage |
plasma aspartate aminotransferase activity level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood aspartate transaminase amount |
male |
448 days
| 8 |
|
|
112.0 |
U/l |
18.0 |
50.91 |
automated plasma aspartate aminotransferase activity assay |
|
0.0 |
|
0 |
|
|
|
138290 |
3201 |
SD-Ldlrem1Sage |
blood very low density lipoprotein particle diameter |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood VLDL particle size |
male |
448 days
| 8 |
|
|
35.8 |
nm |
0.1 |
0.28 |
nuclear magnetic resonance spectroscopy |
|
0.0 |
|
0 |
|
|
|
138331 |
3201 |
Hsd:SD |
plasma creatinine level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood creatinine amount |
male |
448 days
| 9 |
|
|
0.59 |
mg/dl |
0.04 |
0.12 |
automated plasma creatinine analysis |
|
0.0 |
|
0 |
|
|
|
138298 |
3201 |
SD-Ldlrem1Sage |
plasma leptin level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood leptin amount |
male |
448 days
| 8 |
|
|
28.18 |
ng/ml |
4.14 |
11.71 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
138315 |
3201 |
SD-Ldlrem1Sage |
plasma adiponectin level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood adiponectin amount |
male |
448 days
| 8 |
|
|
48.4 |
ug/ml |
5.6 |
15.84 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
138319 |
3201 |
SD-Ldlrem1Sage |
plasma chylomicron and VLDL cholesterol level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood cholesterol amount |
male |
448 days
| 8 |
|
|
178.0 |
mg/dl |
26.0 |
73.54 |
blood cholesterol analysis |
|
0.0 |
|
0 |
|
|
|
138462 |
3201 |
Hsd:SD |
plasma IDL and LDL cholesterol |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood cholesterol amount |
male |
448 days
| 9 |
|
|
94.0 |
mg/dl |
16.0 |
48.0 |
blood cholesterol analysis |
|
0.0 |
|
0 |
|
|
|
138461 |
3201 |
Crl:CD(SD) |
plasma pyruvate level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood pyruvate amount |
male |
70 days
| 19 |
|
|
0.54 |
mg/dl |
0.03 |
0.15 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85338 |
1604 |
Crl:CD(SD) |
plasma lactate level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood lactate amount |
male |
105 days
| 19 |
|
|
15.0 |
mg/dl |
0.48 |
2.1 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85360 |
1604 |
Crl:CD(SD) |
plasma lactate level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood lactate amount |
male |
147 days
| 19 |
|
|
19.4 |
mg/dl |
0.78 |
3.4 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85367 |
1604 |
Crl:CD(SD) |
plasma lactate level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood lactate amount |
male |
78 days
| 19 |
|
|
18.7 |
mg/dl |
1.28 |
5.6 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85357 |
1604 |
Crl:CD(SD) |
body weight |
standard diet then acetaminophen (300 mg/kg) (for 77 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
147 days
| 8 |
|
|
557.0 |
g |
8.13 |
23.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85543 |
1604 |
Crl:CD(SD) |
plasma acetaminophen level |
standard diet and restricted feeding (4 h) (for 114 days) then acetaminophen (500 mg/kg) (for 99 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood acetaminophen amount |
male |
170 days
| 8 |
|
|
2.4 |
ug/ml |
0.71 |
2.0 |
high-performance liquid chromatography |
|
0.0 |
acetaminophen dosing |
1140 |
min |
|
19 hr after dosing |
85585 |
1604 |
Crl:CD(SD) |
plasma acetaminophen level |
standard diet and restricted feeding (4 h) (for 114 days) then acetaminophen (300 mg/kg) (for 99 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood acetaminophen amount |
male |
170 days
| 8 |
|
|
49.3 |
ug/ml |
5.62 |
15.9 |
high-performance liquid chromatography |
|
0.0 |
acetaminophen dosing |
240 |
min |
|
4 hr after dosing |
85580 |
1604 |
WI |
systolic blood pressure |
controlled in utero environment (for 21 days) and standard diet (50 % of calories) (for 21 days) |
Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10. |
arterial blood pressure trait |
male |
102 days
| 35 |
mean of 3 samples of undefined duration |
serial mean |
135.7 |
mmHg |
0.35 |
2.07 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
101056 |
2563 |
WI |
urine sodium excretion rate |
controlled in utero environment (for 21 days) and standard diet (100 % of calories) (for 21 days) |
Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10. |
urine sodium amount |
male |
102 days
| 6 |
|
|
25.67 |
mEq/d |
3.55 |
8.7 |
urine sodium analysis |
|
0.0 |
|
0 |
|
|
|
101061 |
2563 |
Crl:CD(SD) |
body weight |
standard diet and restricted feeding (4 h) then acetaminophen (500 mg/kg) (for 77 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
147 days
| 8 |
|
|
431.0 |
g |
8.49 |
24.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85547 |
1604 |
MHS |
creatinine clearance |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
glomerular filtration trait |
male |
270 days
| 10 |
|
|
0.97 |
ml/min |
0.02 |
0.05 |
creatinine analysis by Jaffe reaction with spectrophotometric readout |
|
0.0 |
|
0 |
|
|
|
104184 |
2927 |
MHS |
body weight |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
body mass |
male |
270 days
| 10 |
|
|
538.6 |
g |
6.77 |
21.4 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
104196 |
2927 |
Crl:WI |
left kidney wet weight to body weight ratio |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
kidney mass |
male |
270 days
| 10 |
|
|
2.9 |
mg/g |
0.09 |
0.3 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
104209 |
2927 |
Crl:CD(SD) |
plasma pyruvate level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood pyruvate amount |
male |
119 days
| 19 |
|
|
0.94 |
mg/dl |
0.09 |
0.39 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85347 |
1604 |
GK/Jcl |
blood total cholesterol level |
standard diet |
Radosinska J, et al., Physiol Res. 2015;64(6):795-806. Epub 2015 Oct 8. |
blood cholesterol amount |
male |
84 days
| 8 |
|
|
83.01 |
mg/dl |
0.96 |
2.7 |
blood cholesterol analysis |
|
0.0 |
|
0 |
|
|
|
103081 |
2785 |
Crl:CD(SD) |
urine taurine excretion rate |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
urine taurine amount |
male |
134 days
| 19 |
|
|
171.1 |
umol/d |
13.08 |
57.0 |
liquid chromatography-mass spectrometry |
|
0.0 |
|
0 |
|
|
|
85399 |
1604 |
Crl:CD(SD) |
liver wet weight |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
liver mass |
male |
170 days
| 19 |
|
|
17.65 |
g |
0.54 |
2.35 |
unspecified method |
|
0.0 |
|
0 |
|
|
liver weight not available |
85402 |
1604 |
Crl:CD(SD) |
plasma aspartate aminotransferase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood aspartate transaminase amount |
male |
119 days
| 19 |
|
|
56.4 |
U/l |
2.13 |
9.3 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85418 |
1604 |
Crl:CD(SD) |
plasma glutamate dehydrogenase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glutamate dehydrogenase amount |
male |
70 days
| 19 |
|
|
15.9 |
U/l |
1.17 |
5.1 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85443 |
1604 |
Crl:CD(SD) |
food intake weight to body weight ratio |
standard diet and restricted feeding (4 h) then acetaminophen (500 mg/kg) (for 35 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
105 days
| 8 |
|
|
4.9 |
g/d/100g |
0.18 |
0.5 |
unspecified method |
|
0.0 |
|
0 |
|
|
on days 32-35 |
85499 |
1604 |
HTG |
plasma total cholesterol level |
standard diet (for 20 days) |
Orolin J, et al., Food Chem Toxicol. 2009 Oct;47(10):2624-30. doi: 10.1016/j.fct.2009.07.022. Epub 2009 Jul 25. |
blood cholesterol amount |
male |
0 days
| 7 |
|
|
60.62 |
mg/dl |
3.09 |
8.17 |
enzymatic cholesterol assay |
|
0.0 |
|
0 |
|
|
|
98904 |
2178 |
HTG |
plasma low density lipoprotein cholesterol level |
standard diet (for 20 days) |
Orolin J, et al., Food Chem Toxicol. 2009 Oct;47(10):2624-30. doi: 10.1016/j.fct.2009.07.022. Epub 2009 Jul 25. |
blood LDL cholesterol amount |
male |
0 days
| 7 |
|
|
14.67 |
mg/dl |
1.54 |
4.09 |
enzymatic cholesterol assay |
|
0.0 |
|
0 |
|
|
|
98912 |
2178 |
Crl:CD(SD) |
plasma aspartate aminotransferase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood aspartate transaminase amount |
male |
168 days
| 19 |
|
|
48.1 |
U/l |
0.69 |
3.0 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85425 |
1604 |
Crl:CD(SD) |
plasma alanine aminotransferase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood alanine transaminase amount |
male |
147 days
| 19 |
|
|
36.4 |
U/l |
0.62 |
2.7 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85438 |
1604 |
Crl:CD(SD) |
plasma glutamate dehydrogenase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glutamate dehydrogenase amount |
male |
147 days
| 19 |
|
|
16.1 |
U/l |
0.69 |
3.0 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85454 |
1604 |
Crl:CD(SD) |
food intake rate |
standard diet and restricted feeding (4 h) then acetaminophen (300 mg/kg) (for 77 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
147 days
| 8 |
|
|
17.9 |
g/d |
1.77 |
5.0 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85480 |
1604 |
Crl:CD(SD) |
body weight |
standard diet and restricted feeding (4 h) then acetaminophen (500 mg/kg) (for 1 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
71 days
| 8 |
|
|
287.0 |
g |
5.3 |
15.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85523 |
1604 |
Crl:CD(SD) |
body weight |
standard diet then acetaminophen (500 mg/kg) (for 1 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
71 days
| 8 |
|
|
375.0 |
g |
6.36 |
18.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85520 |
1604 |
Crl:CD(SD) |
liver wet weight |
standard diet then acetaminophen (500 mg/kg) (for 99 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
liver mass |
male |
170 days
| 8 |
|
|
20.3 |
g |
0.7 |
1.98 |
unspecified method |
|
0.0 |
|
0 |
|
|
liver weight not available |
85556 |
1604 |
Crl:CD(SD) |
plasma lactate level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood lactate amount |
male |
91 days
| 19 |
|
|
18.8 |
mg/dl |
0.53 |
2.3 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85358 |
1604 |
Crl:CD(SD) |
plasma lactate level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood lactate amount |
male |
119 days
| 19 |
|
|
33.2 |
mg/dl |
3.4 |
14.8 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85363 |
1604 |
Crl:CD(SD) |
liver reduced glutathione level to liver weight ratio |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
liver glutathione amount |
male |
170 days
| 19 |
|
|
7.12 |
umol/g |
0.07 |
0.31 |
reduced glutathione/oxidized glutathione enzyme recycling assay |
|
0.0 |
|
0 |
|
enzyme recycling method |
reduced liver glutathione level to liver weight ratio |
85406 |
1604 |
Crl:CD(SD) |
urine taurine excretion rate |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
urine taurine amount |
male |
106 days
| 19 |
|
|
137.6 |
umol/d |
8.44 |
36.8 |
liquid chromatography-mass spectrometry |
|
0.0 |
|
0 |
|
|
|
85396 |
1604 |
Crl:CD(SD) |
liver reduced glutathione level to liver weight ratio |
standard diet and restricted feeding (4 h) (for 114 days) then fasting (for 20 hours) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
liver glutathione amount |
male |
170 days
| 19 |
|
|
6.1 |
umol/g |
0.15 |
0.67 |
reduced glutathione/oxidized glutathione enzyme recycling assay |
|
0.0 |
|
0 |
|
enzyme recycling method |
|
85407 |
1604 |
Crl:CD(SD) |
plasma aspartate aminotransferase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood aspartate transaminase amount |
male |
91 days
| 19 |
|
|
59.7 |
U/l |
0.8 |
3.5 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85415 |
1604 |
Crl:CD(SD) |
plasma aspartate aminotransferase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood aspartate transaminase amount |
male |
133 days
| 19 |
|
|
57.1 |
U/l |
2.18 |
9.5 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85420 |
1604 |
Crl:CD(SD) |
plasma alanine aminotransferase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood alanine transaminase amount |
male |
105 days
| 19 |
|
|
34.9 |
U/l |
1.1 |
4.8 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85432 |
1604 |
Crl:CD(SD) |
plasma alanine aminotransferase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood alanine transaminase amount |
male |
119 days
| 19 |
|
|
37.8 |
U/l |
0.87 |
3.8 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85434 |
1604 |
Crl:CD(SD) |
food intake rate |
standard diet and restricted feeding (4 h) then acetaminophen (500 mg/kg) (for 77 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
147 days
| 8 |
|
|
17.7 |
g/d |
1.31 |
3.7 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85481 |
1604 |
Crl:CD(SD) |
body weight |
standard diet and restricted feeding (4 h) then acetaminophen (500 mg/kg) (for 98 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
168 days
| 8 |
|
|
440.0 |
g |
9.19 |
26.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85553 |
1604 |
Crl:CD(SD) |
food intake rate |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
105 days
| 19 |
|
|
24.5 |
g/d |
0.37 |
1.6 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85291 |
1604 |
Crl:CD(SD) |
food intake weight to body weight ratio |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
168 days
| 19 |
|
|
4.07 |
g/d/100g |
0.05 |
0.2 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85308 |
1604 |
Crl:CD(SD) |
plasma glucose level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glucose amount |
male |
78 days
| 19 |
|
|
126.0 |
mg/dl |
2.06 |
9.0 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85325 |
1604 |
Crl:CD(SD) |
plasma glucose level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glucose amount |
male |
105 days
| 19 |
|
|
121.0 |
mg/dl |
1.61 |
7.0 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85329 |
1604 |
Crl:CD(SD) |
plasma glucose level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glucose amount |
male |
91 days
| 19 |
|
|
124.0 |
mg/dl |
2.29 |
10.0 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85327 |
1604 |
Crl:CD(SD) |
plasma glucose level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glucose amount |
male |
147 days
| 19 |
|
|
126.0 |
mg/dl |
1.84 |
8.0 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85335 |
1604 |
Crl:CD(SD) |
plasma pyruvate level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood pyruvate amount |
male |
168 days
| 19 |
|
|
0.44 |
mg/dl |
0.01 |
0.06 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85352 |
1604 |
Crl:CD(SD) |
plasma pyruvate level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood pyruvate amount |
male |
168 days
| 19 |
|
|
0.56 |
mg/dl |
0.03 |
0.15 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85353 |
1604 |
Crl:CD(SD) |
plasma lactate level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood lactate amount |
male |
105 days
| 19 |
|
|
23.5 |
mg/dl |
2.29 |
10.0 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85361 |
1604 |
Crl:CD(SD) |
urine creatine excretion rate |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
urine creatine amount |
male |
169 days
| 19 |
|
|
2.11 |
umol/d |
0.11 |
0.48 |
liquid chromatography-mass spectrometry |
|
0.0 |
|
0 |
|
|
|
85384 |
1604 |
Crl:CD(SD) |
urine creatine excretion rate |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
urine creatine amount |
male |
169 days
| 19 |
|
|
2.06 |
umol/d |
0.12 |
0.51 |
liquid chromatography-mass spectrometry |
|
0.0 |
|
0 |
|
|
|
85385 |
1604 |
Crl:CD(SD) |
liver wet weight |
standard diet and restricted feeding (4 h) (for 114 days) then fasting (for 20 hours) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
liver mass |
male |
170 days
| 19 |
|
|
11.09 |
g |
0.16 |
0.71 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85403 |
1604 |
Crl:CD(SD) |
plasma alanine aminotransferase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood alanine transaminase amount |
male |
91 days
| 19 |
|
|
33.3 |
U/l |
0.87 |
3.8 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85430 |
1604 |
Crl:CD(SD) |
plasma glutamate dehydrogenase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glutamate dehydrogenase amount |
male |
133 days
| 19 |
|
|
17.0 |
U/l |
0.71 |
3.1 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85452 |
1604 |
Crl:CD(SD) |
food intake rate |
standard diet and restricted feeding (4 h) then acetaminophen (500 mg/kg) (for 35 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
105 days
| 8 |
|
|
16.7 |
g/d |
0.95 |
2.7 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85469 |
1604 |
Crl:CD(SD) |
food intake weight to body weight ratio |
standard diet and restricted feeding (4 h) then acetaminophen (300 mg/kg) (for 14 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
84 days
| 8 |
|
|
6.04 |
g/d/100g |
0.21 |
0.58 |
unspecified method |
|
0.0 |
|
0 |
|
|
on days 11-14 |
85492 |
1604 |
Crl:CD(SD) |
liver oxidized glutathione level to liver weight ratio |
standard diet then acetaminophen (500 mg/kg) (for 99 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
liver glutathione amount |
male |
170 days
| 8 |
|
|
0.19 |
umol/g |
0.01 |
0.03 |
reduced glutathione/oxidized glutathione enzyme recycling assay |
|
0.0 |
|
0 |
|
enzyme recycling method |
reduced liver glutathione level to liver weight ratio |
85574 |
1604 |
Crl:CD(SD) |
plasma glucose level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glucose amount |
male |
119 days
| 19 |
|
|
127.0 |
mg/dl |
1.84 |
8.0 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85331 |
1604 |
Crl:CD(SD) |
plasma acetaminophen level |
standard diet then acetaminophen (300 mg/kg) (for 99 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood acetaminophen amount |
male |
170 days
| 8 |
|
|
0.3 |
ug/ml |
0.18 |
0.5 |
high-performance liquid chromatography |
|
0.0 |
acetaminophen dosing |
1140 |
min |
|
19 hr after dosing |
85582 |
1604 |
Crl:CD(SD) |
plasma acetaminophen level |
standard diet then acetaminophen (300 mg/kg) (for 99 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood acetaminophen amount |
male |
170 days
| 8 |
|
|
88.0 |
ug/ml |
3.89 |
11.0 |
high-performance liquid chromatography |
|
0.0 |
acetaminophen dosing |
240 |
min |
|
4 hr after dosing |
85578 |
1604 |
Crl:CD(SD) |
liver reduced glutathione level to liver weight ratio |
standard diet and restricted feeding (4 h) (for 114 days) then acetaminophen (300 mg/kg) (for 99 days) then fasting (for 20 hours) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
liver glutathione amount |
male |
170 days
| 8 |
|
|
6.24 |
umol/g |
0.31 |
0.87 |
reduced glutathione/oxidized glutathione enzyme recycling assay |
|
0.0 |
|
0 |
|
enzyme recycling method |
|
85570 |
1604 |
Crl:CD(SD) |
food intake weight to body weight ratio |
standard diet and restricted feeding (4 h) then acetaminophen (500 mg/kg) (for 77 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
147 days
| 8 |
|
|
4.03 |
g/d/100g |
0.29 |
0.81 |
unspecified method |
|
0.0 |
|
0 |
|
|
on days 74-77 |
85511 |
1604 |
Crl:CD(SD) |
body weight |
standard diet then acetaminophen (300 mg/kg) (for 14 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
84 days
| 8 |
|
|
418.0 |
g |
6.72 |
19.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85525 |
1604 |
Jcl:WI |
heart weight |
standard diet |
Radosinska J, et al., Physiol Res. 2015;64(6):795-806. Epub 2015 Oct 8. |
heart mass |
male |
84 days
| 8 |
|
|
1.14 |
g |
0.03 |
0.09 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
103059 |
2785 |
Jcl:WI |
blood glucose level |
standard diet |
Radosinska J, et al., Physiol Res. 2015;64(6):795-806. Epub 2015 Oct 8. |
blood glucose amount |
male |
84 days
| 8 |
|
|
162.36 |
mg/dl |
16.1 |
45.54 |
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
103071 |
2785 |
SS |
body weight |
standard diet |
Wu F, et al., Int J Hypertens. 2016;2016:9146870. doi: 10.1155/2016/9146870. Epub 2016 Dec 19. |
body mass |
male |
49 days
| 8 |
|
|
208.0 |
g |
2.72 |
7.7 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
102270 |
2683 |
WKY |
liver triglyceride level |
standard diet (for 20 days) |
Orolin J, et al., Food Chem Toxicol. 2009 Oct;47(10):2624-30. doi: 10.1016/j.fct.2009.07.022. Epub 2009 Jul 25. |
liver triglyceride amount |
male |
0 days
| 7 |
|
|
11.42 |
mg/g |
1.08 |
2.86 |
enzymatic triglyceride assay |
|
0.0 |
|
0 |
|
|
|
98898 |
2178 |
HTG |
plasma high density lipoprotein cholesterol level |
standard diet (for 20 days) |
Orolin J, et al., Food Chem Toxicol. 2009 Oct;47(10):2624-30. doi: 10.1016/j.fct.2009.07.022. Epub 2009 Jul 25. |
blood HDL cholesterol amount |
male |
0 days
| 7 |
|
|
31.27 |
mg/dl |
2.32 |
6.13 |
enzymatic cholesterol assay |
|
0.0 |
|
0 |
|
|
|
98916 |
2178 |
SS |
urine sodium level |
standard diet |
Wu F, et al., Int J Hypertens. 2016;2016:9146870. doi: 10.1155/2016/9146870. Epub 2016 Dec 19. |
urine sodium amount |
male |
49 days
| 8 |
|
|
0.5 |
mmol/l |
0.07 |
0.2 |
urine sodium analysis |
|
0.0 |
|
0 |
|
|
|
102280 |
2683 |
SHR/N-cp |
serum glucose level |
standard diet (between 28 and 42 days) then controlled carbohydrate content diet (54 %) (between 140 and 154 days) |
Velasquez MT, et al., Hypertension. 1997 Nov;30(5):1232-7. |
blood glucose amount |
male |
168 days-196 days |
8 |
|
|
130.68 |
mg/dl |
21.78 |
61.6 |
serum glucose analysis |
|
0.0 |
|
0 |
|
|
|
101508 |
2601 |
SHR/N-cp |
serum glucose level |
standard diet (between 28 and 42 days) then controlled carbohydrate content diet (54 %) (between 112 and 126 days) then perindopril (0.25-0.5 mg/kg/d) (between 56 and 70 days) |
Velasquez MT, et al., Hypertension. 1997 Nov;30(5):1232-7. |
blood glucose amount |
male |
140 days-168 days |
8 |
|
|
179.69 |
mg/dl |
21.78 |
61.6 |
serum glucose analysis |
|
0.0 |
|
0 |
|
|
|
101506 |
2601 |
SHR/N-cp |
serum glucose level |
standard diet (between 28 and 42 days) then controlled carbohydrate content diet (54 %) (between 140 and 154 days) then perindopril (0.25-0.5 mg/kg/d) (between 84 and 98 days) |
Velasquez MT, et al., Hypertension. 1997 Nov;30(5):1232-7. |
blood glucose amount |
male |
168 days-196 days |
8 |
|
|
139.76 |
mg/dl |
18.15 |
51.34 |
serum glucose analysis |
|
0.0 |
|
0 |
|
|
|
101509 |
2601 |
SHR/N-cp |
both kidneys wet weight to body weight ratio |
standard diet (between 28 and 42 days) then controlled carbohydrate content diet (54 %) (between 140 and 154 days) then perindopril (0.25-0.5 mg/kg/d) (between 84 and 98 days) |
Velasquez MT, et al., Hypertension. 1997 Nov;30(5):1232-7. |
kidney mass |
male |
168 days-196 days |
8 |
|
|
1.67 |
g/kg |
0.1 |
0.28 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
101524 |
2601 |
SHR/N-cp |
kidney sclerotic glomeruli count to total glomeruli count ratio |
standard diet (between 28 and 42 days) then controlled carbohydrate content diet (54 %) (between 140 and 154 days) |
Velasquez MT, et al., Hypertension. 1997 Nov;30(5):1232-7. |
kidney glomerulus integrity trait |
male |
168 days-196 days |
8 |
|
|
16.0 |
% |
3.0 |
8.49 |
ex vivo light microscopy with histochemistry |
|
0.0 |
|
0 |
|
|
|
101526 |
2601 |
SHR/N-cp |
plasma renin activity level |
standard diet (between 28 and 42 days) then controlled carbohydrate content diet (54 %) (between 140 and 154 days) then controlled hydralazine content drinking water (30 mg/l) (between 84 and 98 days) and hydralazine (50 mg/l) (between 84 and 98 days) and reserpine (4 mg/l) (between 84 and 98 days) |
Velasquez MT, et al., Hypertension. 1997 Nov;30(5):1232-7. |
renin activity |
male |
140 days-168 days |
8 |
|
|
38.0 |
ng/ml/h |
2.0 |
5.66 |
radioimmunoassay |
|
0.0 |
|
0 |
|
|
|
101534 |
2601 |
WI |
urine sodium excretion rate |
controlled in utero environment (for 21 days) and standard diet (50 % of calories) (for 21 days) |
Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10. |
urine sodium amount |
male |
102 days
| 6 |
|
|
35.17 |
mEq/d |
6.7 |
16.41 |
urine sodium analysis |
|
0.0 |
|
0 |
|
|
|
101062 |
2563 |
SD-Lepem1Sage+/+ |
blood glucose level |
fasting (for 16 hours) then standard diet (for 1 hours) |
D'souza AM, et al., Endocrinology. 2014 Apr;155(4):1268-79. doi: 10.1210/en.2013-1523. Epub 2014 Jan 27. |
blood glucose amount |
male |
91 days
| 6 |
|
|
109.08 |
mg/dl |
3.6 |
8.82 |
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
104470 |
2949 |
SD-Abcc6em2Qlju+/+ |
serum calcium to serum phosphate ratio |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood calcium amount |
male |
60 days-180 days |
5 |
|
|
1.56 |
null |
0.06 |
0.13 |
colorimetry |
|
0.0 |
|
0 |
|
|
|
104648 |
2972 |
SD-Abcc6em2Qlju+/+ |
plasma pyrophosphate level |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood pyrophosphate amount |
female |
60 days-180 days |
5 |
|
|
0.77 |
umol/l |
0.11 |
0.25 |
enzymatic method |
|
0.0 |
|
0 |
|
|
|
104655 |
2972 |
SD-Abcc6em2Qlju+/- |
plasma pyrophosphate level |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood pyrophosphate amount |
male |
60 days-180 days |
5 |
|
|
0.61 |
umol/l |
0.08 |
0.18 |
enzymatic method |
|
0.0 |
|
0 |
|
|
|
104656 |
2972 |
MNS |
timed urine volume |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
urine output |
male |
270 days
| 10 |
|
|
14.4 |
ml/d |
1.56 |
4.93 |
urine volume measurement method |
|
0.0 |
|
0 |
|
|
|
104171 |
2927 |
MHS |
body weight |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
body mass |
male |
63 days
| 10 |
|
|
235.0 |
g |
1.87 |
5.9 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
104194 |
2927 |
MHS |
body weight |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
body mass |
male |
63 days
| 10 |
|
|
544.4 |
g |
11.45 |
36.2 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
104197 |
2927 |
MHS |
left kidney wet weight |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
kidney mass |
male |
270 days
| 10 |
|
|
1.13 |
g |
0.02 |
0.07 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
104202 |
2927 |
MNS |
artery diameter |
standard diet (for 63 days) |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
kidney blood vessel morphology trait |
male |
63 days
| 10 |
|
|
35.8 |
um |
1.55 |
4.9 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
0 |
|
|
|
104210 |
2927 |
MWF/Ztm |
total pericapillary slit length |
standard diet |
Iordache BE, etal., J Am Soc Nephrol. 1994 Dec;5(6):1378-84. |
podocyte morphology trait |
male |
252 days-253 days |
5 |
|
|
786.37 |
mm |
54.38 |
121.6 |
ex vivo electron microscopy with digital image analysis |
|
0.0 |
|
0 |
|
|
|
109183 |
3136 |
MWF/Ztm |
mesangium volume per glomerulus |
standard diet |
Iordache BE, etal., J Am Soc Nephrol. 1994 Dec;5(6):1378-84. |
kidney glomerulus morphology trait |
male |
252 days-253 days |
5 |
Pc/Pr, number of grid points falling into the component (Pc: mesangial cells and matrix) and the number of points falling into the reference area (Pr. i.e., the glomerular tuft |
|
0.21 |
x 10E-6 um3 |
0.02 |
0.04 |
ex vivo electron microscopy with digital image analysis |
renal glomerulus |
0.0 |
|
0 |
|
|
mesangium volume per glomerulus (CMO:0003716) |
109172 |
3136 |
MWF/Ztm |
podocyte foot process width |
standard diet |
Iordache BE, etal., J Am Soc Nephrol. 1994 Dec;5(6):1378-84. |
podocyte morphology trait |
male |
131 days
| 6 |
|
|
227.0 |
nm |
7.76 |
19.0 |
ex vivo electron microscopy with digital image analysis |
|
0.0 |
|
0 |
|
|
|
109186 |
3136 |
MWF/Ztm |
systolic blood pressure |
standard diet |
Remuzzi A, etal., Am J Kidney Dis. 1999 Oct;34(4):626-32. doi: 10.1016/S0272-6386(99)70385-9. |
arterial blood pressure trait |
male |
140 days
| 10 |
|
|
150.0 |
mmHg |
6.64 |
21.0 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
109977 |
3162 |
MWF/Ztm |
systolic blood pressure |
standard diet |
Remuzzi A, etal., Am J Kidney Dis. 1999 Oct;34(4):626-32. doi: 10.1016/S0272-6386(99)70385-9. |
arterial blood pressure trait |
male |
140 days
| 7 |
|
|
153.0 |
mmHg |
5.67 |
15.0 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
109978 |
3162 |
MWF/Fub |
kidney wet weight to body weight ratio |
standard diet |
Kreutz R, etal., J Hypertens. 2000 Jun;18(6):777-82. doi: 10.1097/00004872-200018060-00017. |
kidney mass |
female |
104 days
| 8 |
|
|
2.82 |
mg/g |
0.07 |
0.2 |
post excision weight measurement |
kidney |
0.0 |
|
0 |
|
|
|
109016 |
3134 |
SHRSP/A3NCrl |
partial pressure of brain white matter oxygen |
standard diet |
Weaver J, etal., J Cereb Blood Flow Metab. 2014 May;34(5):890-6. doi: 10.1038/jcbfm.2014.35. Epub 2014 Feb 19. |
brain oxygen amount |
male |
91 days
| 6 |
|
|
24.2 |
mmHg |
1.2 |
2.94 |
electron paramagnetic resonance oximetry |
white matter |
40.0 |
|
0 |
|
5 scans x 40 seconds |
vascular cognitive impairment |
107315 |
3080 |
MWF/Fub |
kidney weight |
standard diet |
Kreutz R, etal., J Hypertens. 2000 Jun;18(6):777-82. doi: 10.1097/00004872-200018060-00017. |
kidney mass |
male |
104 days
| 8 |
|
|
0.91 |
g |
0.03 |
0.08 |
post excision weight measurement |
kidney |
0.0 |
|
0 |
|
|
|
109009 |
3134 |
Hsd:SD |
plasma albumin level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood albumin amount |
male |
448 days
| 9 |
|
|
0.36 |
g/l |
0.01 |
0.02 |
automated plasma albumin analysis |
|
0.0 |
|
0 |
|
|
|
138276 |
3201 |
Hsd:SD |
plasma alanine aminotransferase activity level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood alanine transaminase amount |
male |
448 days
| 9 |
|
|
54.0 |
U/l |
6.0 |
18.0 |
automated plasma alanine aminotransferase activity assay |
|
0.0 |
|
0 |
|
|
|
138285 |
3201 |
SD-Ldlrem1Sage |
plasma creatine kinase activity level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood creatine kinase amount |
male |
448 days
| 8 |
|
|
354.0 |
U/l |
90.0 |
254.56 |
automated plasma creatine kinase activity assay |
|
0.0 |
|
0 |
|
|
CK |
138295 |
3201 |
SD-Ldlrem1Sage |
liver triglyceride level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
liver triglyceride amount |
male |
448 days
| 8 |
|
|
25.76 |
mg/g |
5.72 |
16.18 |
isolated tissue triglyceride measurement test |
|
0.0 |
|
0 |
|
|
|
138347 |
3201 |
Hsd:SD |
liver cholesterol level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
liver cholesterol amount |
male |
448 days
| 9 |
|
|
5.39 |
mg/g |
0.14 |
0.42 |
isolated tissue cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
138342 |
3201 |
Hsd:SD |
plasma adiponectin level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood adiponectin amount |
male |
448 days
| 9 |
|
|
82.96 |
ug/ml |
4.73 |
14.19 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
138318 |
3201 |
SD-Ldlrem1Sage |
plasma high density lipoprotein cholesterol level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood cholesterol amount |
male |
448 days
| 8 |
|
|
73.0 |
mg/dl |
6.0 |
16.97 |
blood cholesterol analysis |
|
0.0 |
|
0 |
|
|
|
138327 |
3201 |
SD-Ldlrem1Sage |
plasma IDL and LDL cholesterol |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood cholesterol amount |
male |
448 days
| 8 |
|
|
168.0 |
mg/dl |
8.0 |
22.63 |
blood cholesterol analysis |
|
0.0 |
|
0 |
|
|
|
138463 |
3201 |
Crl:CD(SD) |
food intake weight to body weight ratio |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
126 days
| 19 |
|
|
4.62 |
g/d/100g |
0.13 |
0.56 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85305 |
1604 |
Crl:CD(SD) |
body weight |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
71 days
| 19 |
|
|
373.0 |
g |
4.59 |
20.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85310 |
1604 |
Crl:CD(SD) |
plasma glucose level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glucose amount |
male |
133 days
| 19 |
|
|
134.0 |
mg/dl |
1.15 |
5.0 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85332 |
1604 |
Crl:CD(SD) |
plasma creatinine level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood creatinine amount |
male |
168 days
| 19 |
|
|
0.43 |
mg/dl |
0.0 |
0.01 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85376 |
1604 |
Crl:CD(SD) |
urine creatine excretion rate |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
urine creatine amount |
male |
70 days
| 19 |
|
|
1.05 |
umol/d |
0.04 |
0.19 |
liquid chromatography-mass spectrometry |
|
0.0 |
|
0 |
|
|
|
85379 |
1604 |
Crl:CD(SD) |
body weight |
standard diet and restricted feeding (4 h) then acetaminophen (300 mg/kg) (for 56 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
126 days
| 8 |
|
|
404.0 |
g |
12.37 |
35.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85540 |
1604 |
Crl:CD(SD) |
liver reduced glutathione level to liver weight ratio |
standard diet then acetaminophen (500 mg/kg) (for 99 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
liver glutathione amount |
male |
170 days
| 8 |
|
|
9.07 |
umol/g |
0.25 |
0.72 |
reduced glutathione/oxidized glutathione enzyme recycling assay |
|
0.0 |
|
0 |
|
enzyme recycling method |
reduced liver glutathione level to liver weight ratio |
85568 |
1604 |
WI |
serum sodium level |
controlled in utero environment (for 21 days) and standard diet (50 % of calories) (for 21 days) |
Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10. |
blood sodium amount |
male |
102 days
| 6 |
|
|
126.67 |
mmol/l |
1.31 |
3.21 |
automated serum sodium test |
|
0.0 |
|
0 |
|
|
|
101058 |
2563 |
WI |
serum urea nitrogen level |
controlled in utero environment (for 21 days) and standard diet (100 % of calories) (for 21 days) |
Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10. |
blood urea nitrogen amount |
male |
102 days
| 6 |
|
|
37.33 |
mg/dl |
2.68 |
6.56 |
serum urea nitrogen analysis |
|
0.0 |
|
0 |
|
|
|
101067 |
2563 |
WI |
urine potassium excretion rate |
controlled in utero environment (for 21 days) and standard diet (50 % of calories) (for 21 days) |
Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10. |
urine potassium amount |
male |
102 days
| 6 |
|
|
73.83 |
mEq/d |
6.23 |
15.26 |
urine potassium analysis |
|
0.0 |
|
0 |
|
|
|
101064 |
2563 |
SD-Abcc6em2Qlju+/+ |
serum phosphate level |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood phosphate amount |
female |
60 days-180 days |
5 |
|
|
5.9 |
mg/dl |
0.2 |
0.45 |
liquid phase colorimetry |
|
0.0 |
|
0 |
|
|
|
104643 |
2972 |
SD-Abcc6em2Qlju+/- |
plasma pyrophosphate level |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood pyrophosphate amount |
female |
60 days-180 days |
5 |
|
|
0.53 |
umol/l |
0.04 |
0.09 |
enzymatic method |
|
0.0 |
|
0 |
|
|
|
104657 |
2972 |
Crl:WI |
timed urine volume |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
urine output |
male |
63 days
| 10 |
|
|
14.8 |
ml/d |
1.35 |
4.27 |
urine volume measurement method |
|
0.0 |
|
0 |
|
|
|
104170 |
2927 |
SS |
plasma urotensin II level |
standard diet |
Wu F, et al., Int J Hypertens. 2016;2016:9146870. doi: 10.1155/2016/9146870. Epub 2016 Dec 19. |
blood urotensin II amount |
male |
49 days
| 8 |
|
|
51.0 |
pg/ml |
0.85 |
2.4 |
radioimmunoassay |
|
0.0 |
|
0 |
|
|
|
102274 |
2683 |
Crl:CD(SD) |
body weight |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
168 days
| 19 |
|
|
588.0 |
g |
14.45 |
63.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85320 |
1604 |
Crl:CD(SD) |
plasma pyruvate level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood pyruvate amount |
male |
147 days
| 19 |
|
|
0.68 |
mg/dl |
0.1 |
0.42 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85351 |
1604 |
Crl:CD(SD) |
plasma alanine aminotransferase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood alanine transaminase amount |
male |
119 days
| 19 |
|
|
36.8 |
U/l |
1.19 |
5.2 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85435 |
1604 |
Crl:CD(SD) |
food intake weight to body weight ratio |
standard diet and restricted feeding (4 h) then acetaminophen (500 mg/kg) (for 98 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
168 days
| 8 |
|
|
4.34 |
g/d/100g |
0.34 |
0.96 |
unspecified method |
|
0.0 |
|
0 |
|
|
on days 95-98 |
85517 |
1604 |
HTG |
plasma very low density lipoprotein cholesterol level |
standard diet (for 20 days) |
Orolin J, et al., Food Chem Toxicol. 2009 Oct;47(10):2624-30. doi: 10.1016/j.fct.2009.07.022. Epub 2009 Jul 25. |
blood VLDL cholesterol amount |
male |
0 days
| 7 |
|
|
4.25 |
mg/dl |
1.16 |
3.06 |
enzymatic cholesterol assay |
|
0.0 |
|
0 |
|
|
|
98908 |
2178 |
WKY |
plasma high density lipoprotein cholesterol level |
standard diet (for 20 days) |
Orolin J, et al., Food Chem Toxicol. 2009 Oct;47(10):2624-30. doi: 10.1016/j.fct.2009.07.022. Epub 2009 Jul 25. |
blood HDL cholesterol amount |
male |
0 days
| 7 |
|
|
28.57 |
mg/dl |
1.16 |
3.06 |
enzymatic cholesterol assay |
|
0.0 |
|
0 |
|
|
|
98914 |
2178 |
Crl:CD(SD) |
plasma alanine aminotransferase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood alanine transaminase amount |
male |
133 days
| 19 |
|
|
35.9 |
U/l |
0.87 |
3.8 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85436 |
1604 |
Crl:CD(SD) |
plasma glutamate dehydrogenase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glutamate dehydrogenase amount |
male |
168 days
| 19 |
|
|
14.3 |
U/l |
0.8 |
3.5 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85456 |
1604 |
Crl:CD(SD) |
plasma glutamate dehydrogenase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glutamate dehydrogenase amount |
male |
133 days
| 19 |
|
|
13.4 |
U/l |
0.3 |
1.3 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85453 |
1604 |
Crl:CD(SD) |
food intake weight to body weight ratio |
standard diet and restricted feeding (4 h) then acetaminophen (300 mg/kg) (for 77 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
147 days
| 8 |
|
|
4.37 |
g/d/100g |
0.23 |
0.66 |
unspecified method |
|
0.0 |
|
0 |
|
|
on days 74-77 |
85510 |
1604 |
Crl:CD(SD) |
body weight |
standard diet then acetaminophen (500 mg/kg) (for 14 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
84 days
| 8 |
|
|
413.0 |
g |
6.01 |
17.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85526 |
1604 |
Crl:CD(SD) |
body weight |
standard diet then acetaminophen (500 mg/kg) (for 77 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
147 days
| 8 |
|
|
549.0 |
g |
12.73 |
36.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85544 |
1604 |
Crl:CD(SD) |
food intake rate |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
84 days
| 19 |
|
|
17.0 |
g/d |
0.73 |
3.2 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85292 |
1604 |
Crl:CD(SD) |
body weight |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
105 days
| 19 |
|
|
481.0 |
g |
11.7 |
51.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85314 |
1604 |
Crl:CD(SD) |
plasma pyruvate level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood pyruvate amount |
male |
70 days
| 19 |
|
|
0.57 |
mg/dl |
0.04 |
0.18 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85339 |
1604 |
Crl:CD(SD) |
plasma creatinine level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood creatinine amount |
male |
105 days
| 19 |
|
|
0.38 |
mg/dl |
0.0 |
0.02 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85372 |
1604 |
Crl:CD(SD) |
urine creatine excretion rate |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
urine creatine amount |
male |
70 days
| 19 |
|
|
1.67 |
umol/d |
0.05 |
0.22 |
liquid chromatography-mass spectrometry |
|
0.0 |
|
0 |
|
|
|
85378 |
1604 |
Crl:CD(SD) |
plasma creatinine level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood creatinine amount |
male |
168 days
| 19 |
|
|
0.46 |
mg/dl |
0.0 |
0.02 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85377 |
1604 |
Crl:CD(SD) |
urine creatine excretion rate |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
urine creatine amount |
male |
106 days
| 19 |
|
|
2.22 |
umol/d |
0.07 |
0.31 |
liquid chromatography-mass spectrometry |
|
0.0 |
|
0 |
|
|
|
85380 |
1604 |
Crl:CD(SD) |
urine creatinine excretion rate |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
urine creatinine amount |
male |
134 days
| 19 |
|
|
12.5 |
mg/d |
0.25 |
1.11 |
liquid chromatography-mass spectrometry |
|
0.0 |
|
0 |
|
|
|
85391 |
1604 |
Crl:CD(SD) |
urine taurine excretion rate |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
urine taurine amount |
male |
70 days
| 19 |
|
|
58.1 |
umol/d |
5.41 |
23.6 |
liquid chromatography-mass spectrometry |
|
0.0 |
|
0 |
|
|
|
85395 |
1604 |
Crl:CD(SD) |
liver oxidized glutathione level to liver weight ratio |
standard diet and restricted feeding (4 h) (for 114 days) then fasting (for 20 hours) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
liver glutathione amount |
male |
170 days
| 19 |
|
|
0.17 |
umol/g |
0.0 |
0.02 |
reduced glutathione/oxidized glutathione enzyme recycling assay |
|
0.0 |
|
0 |
|
enzyme recycling method |
|
85409 |
1604 |
Crl:CD(SD) |
plasma aspartate aminotransferase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood aspartate transaminase amount |
male |
105 days
| 19 |
|
|
58.4 |
U/l |
1.06 |
4.6 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85417 |
1604 |
Crl:CD(SD) |
plasma alanine aminotransferase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood alanine transaminase amount |
male |
105 days
| 19 |
|
|
34.0 |
U/l |
1.35 |
5.9 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85433 |
1604 |
Crl:CD(SD) |
plasma glutamate dehydrogenase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glutamate dehydrogenase amount |
male |
91 days
| 19 |
|
|
14.4 |
U/l |
1.19 |
5.2 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85446 |
1604 |
Crl:CD(SD) |
food intake rate |
standard diet then acetaminophen (300 mg/kg) (for 14 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
84 days
| 8 |
|
|
24.1 |
g/d |
0.53 |
1.5 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85459 |
1604 |
Crl:CD(SD) |
plasma glutamate dehydrogenase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glutamate dehydrogenase amount |
male |
119 days
| 19 |
|
|
15.0 |
U/l |
0.55 |
2.4 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85451 |
1604 |
Crl:CD(SD) |
plasma glutamate dehydrogenase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glutamate dehydrogenase amount |
male |
147 days
| 19 |
|
|
13.4 |
U/l |
0.41 |
1.8 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85455 |
1604 |
Crl:CD(SD) |
food intake weight to body weight ratio |
standard diet then acetaminophen (300 mg/kg) (for 35 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
105 days
| 8 |
|
|
5.2 |
g/d/100g |
0.07 |
0.21 |
unspecified method |
|
0.0 |
|
0 |
|
|
on days 32-35 |
85495 |
1604 |
Crl:CD(SD) |
body weight |
standard diet then acetaminophen (300 mg/kg) (for 56 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
126 days
| 8 |
|
|
522.0 |
g |
8.13 |
23.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85537 |
1604 |
Crl:CD(SD) |
body weight |
standard diet and restricted feeding (4 h) then acetaminophen (300 mg/kg) (for 1 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
71 days
| 8 |
|
|
287.0 |
g |
6.72 |
19.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85522 |
1604 |
Crl:CD(SD) |
body weight |
standard diet then acetaminophen (300 mg/kg) (for 98 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
168 days
| 8 |
|
|
581.0 |
g |
9.19 |
26.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85549 |
1604 |
Crl:CD(SD) |
liver wet weight |
standard diet then acetaminophen (300 mg/kg) (for 99 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
liver mass |
male |
170 days
| 8 |
|
|
20.1 |
g |
0.47 |
1.33 |
unspecified method |
|
0.0 |
|
0 |
|
|
liver weight not available |
85555 |
1604 |
Crl:CD(SD) |
plasma acetaminophen level |
standard diet and restricted feeding (4 h) (for 114 days) then acetaminophen (300 mg/kg) (for 99 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood acetaminophen amount |
male |
170 days
| 8 |
|
|
0.6 |
ug/ml |
0.21 |
0.6 |
high-performance liquid chromatography |
|
0.0 |
acetaminophen dosing |
1140 |
min |
|
19 hr after dosing |
85584 |
1604 |
Crl:CD(SD) |
food intake rate |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
126 days
| 19 |
|
|
24.8 |
g/d |
0.53 |
2.3 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85294 |
1604 |
Crl:CD(SD) |
food intake rate |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
84 days
| 19 |
|
|
24.7 |
g/d |
0.48 |
2.1 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85290 |
1604 |
Crl:CD(SD) |
food intake weight to body weight ratio |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
84 days
| 19 |
|
|
6.11 |
g/d/100g |
0.1 |
0.45 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85301 |
1604 |
Crl:CD(SD) |
plasma creatinine level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood creatinine amount |
male |
70 days
| 19 |
|
|
0.38 |
mg/dl |
0.0 |
0.02 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85371 |
1604 |
Crl:CD(SD) |
urine taurine excretion rate |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
urine taurine amount |
male |
106 days
| 19 |
|
|
142.0 |
umol/d |
12.64 |
55.1 |
liquid chromatography-mass spectrometry |
|
0.0 |
|
0 |
|
|
|
85397 |
1604 |
Crl:CD(SD) |
urine taurine excretion rate |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
urine taurine amount |
male |
169 days
| 19 |
|
|
129.3 |
umol/d |
8.3 |
36.2 |
liquid chromatography-mass spectrometry |
|
0.0 |
|
0 |
|
|
|
85400 |
1604 |
Crl:CD(SD) |
plasma alanine aminotransferase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood alanine transaminase amount |
male |
168 days
| 19 |
|
|
37.3 |
U/l |
0.96 |
4.2 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85440 |
1604 |
Crl:CD(SD) |
plasma acetaminophen level area under curve |
standard diet then acetaminophen (500 mg/kg) (for 99 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood acetaminophen amount |
male |
170 days
| 8 |
|
|
893.3 |
(ug/ml) x h |
44.55 |
126.0 |
high-performance liquid chromatography |
|
0.0 |
acetaminophen dosing |
1140 |
min |
4-19 hr dosing |
4-19 hr dosing |
85587 |
1604 |
Crl:CD(SD) |
plasma acetaminophen level |
standard diet then acetaminophen (500 mg/kg) (for 99 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood acetaminophen amount |
male |
170 days
| 8 |
|
|
1.1 |
ug/ml |
0.32 |
0.9 |
high-performance liquid chromatography |
|
0.0 |
acetaminophen dosing |
1140 |
min |
|
19 hr after dosing |
85583 |
1604 |
Crl:CD(SD) |
plasma acetaminophen level |
standard diet and restricted feeding (4 h) (for 114 days) then acetaminophen (500 mg/kg) (for 99 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood acetaminophen amount |
male |
170 days
| 8 |
|
|
64.3 |
ug/ml |
9.72 |
27.5 |
high-performance liquid chromatography |
|
0.0 |
acetaminophen dosing |
240 |
min |
|
4 hr after dosing |
85581 |
1604 |
Crl:CD(SD) |
plasma aspartate aminotransferase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood aspartate transaminase amount |
male |
168 days
| 19 |
|
|
52.7 |
U/l |
1.26 |
5.5 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85424 |
1604 |
Crl:CD(SD) |
food intake rate |
standard diet and restricted feeding (4 h) then acetaminophen (500 mg/kg) (for 56 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
126 days
| 8 |
|
|
18.7 |
g/d |
1.45 |
4.1 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85475 |
1604 |
Crl:CD(SD) |
plasma acetaminophen level area under curve |
standard diet and restricted feeding (4 h) (for 114 days) then acetaminophen (500 mg/kg) (for 99 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood acetaminophen amount |
male |
170 days
| 8 |
|
|
500.6 |
(ug/ml) x h |
64.42 |
182.2 |
high-performance liquid chromatography |
|
0.0 |
acetaminophen dosing |
1140 |
min |
4-19 hr dosing |
4-19 hr dosing |
85589 |
1604 |
GK/Jcl |
heart left ventricle weight |
standard diet |
Radosinska J, et al., Physiol Res. 2015;64(6):795-806. Epub 2015 Oct 8. |
heart left ventricle mass |
male |
84 days
| 8 |
|
|
0.68 |
g |
0.01 |
0.03 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
103065 |
2785 |
Jcl:WI |
blood triglyceride level |
standard diet |
Radosinska J, et al., Physiol Res. 2015;64(6):795-806. Epub 2015 Oct 8. |
blood triglyceride amount |
male |
84 days
| 8 |
|
|
47.79 |
mg/dl |
4.38 |
12.39 |
blood triglyceride analysis |
|
0.0 |
|
0 |
|
|
|
103075 |
2785 |
SS |
mean arterial blood pressure |
standard diet |
Wu F, et al., Int J Hypertens. 2016;2016:9146870. doi: 10.1155/2016/9146870. Epub 2016 Dec 19. |
arterial blood pressure trait |
male |
49 days
| 8 |
|
|
124.0 |
mmHg |
2.12 |
6.0 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
102266 |
2683 |
SR/Hsd |
body weight |
standard diet |
Wu F, et al., Int J Hypertens. 2016;2016:9146870. doi: 10.1155/2016/9146870. Epub 2016 Dec 19. |
body mass |
male |
49 days
| 8 |
|
|
213.0 |
g |
2.4 |
6.8 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
102271 |
2683 |
Jcl:WI |
blood total cholesterol level |
standard diet |
Radosinska J, et al., Physiol Res. 2015;64(6):795-806. Epub 2015 Oct 8. |
blood cholesterol amount |
male |
84 days
| 8 |
|
|
51.74 |
mg/dl |
2.59 |
7.34 |
blood cholesterol analysis |
|
0.0 |
|
0 |
|
|
|
103079 |
2785 |
WKY |
liver cholesterol level |
standard diet (for 20 days) |
Orolin J, et al., Food Chem Toxicol. 2009 Oct;47(10):2624-30. doi: 10.1016/j.fct.2009.07.022. Epub 2009 Jul 25. |
liver cholesterol amount |
male |
0 days
| 7 |
|
|
3.92 |
mg/g |
0.24 |
0.63 |
enzymatic cholesterol assay |
|
0.0 |
|
0 |
|
|
|
98894 |
2178 |
HTG |
blood very low density lipoprotein triglyceride level |
standard diet (for 20 days) |
Orolin J, et al., Food Chem Toxicol. 2009 Oct;47(10):2624-30. doi: 10.1016/j.fct.2009.07.022. Epub 2009 Jul 25. |
blood VLDL triglyceride amount |
male |
0 days
| 7 |
|
|
1.84 |
mg/dl |
0.36 |
0.95 |
enzymatic triglyceride assay |
|
0.0 |
|
0 |
|
|
|
98924 |
2178 |
WI |
body weight |
controlled in utero environment (for 21 days) and standard diet (50 % of calories) (for 21 days) |
Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10. |
body mass |
male |
68 days
| 35 |
|
|
303.6 |
g |
6.5 |
38.45 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
101054 |
2563 |
WI |
serum potassium level |
controlled in utero environment (for 21 days) and standard diet (50 % of calories) (for 21 days) |
Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10. |
blood potassium amount |
male |
102 days
| 6 |
|
|
3.67 |
mmol/l |
0.21 |
0.51 |
automated serum potassium test |
|
0.0 |
|
0 |
|
|
|
101060 |
2563 |
WI |
serum sodium level |
controlled in utero environment (for 21 days) and standard diet (100 % of calories) (for 21 days) |
Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10. |
blood sodium amount |
male |
102 days
| 6 |
|
|
128.66 |
mmol/l |
1.8 |
4.41 |
automated serum sodium test |
|
0.0 |
|
0 |
|
|
|
101057 |
2563 |
SHR/N-cp |
both kidneys wet weight to body weight ratio |
standard diet (between 28 and 42 days) then controlled carbohydrate content diet (54 %) (between 140 and 154 days) then controlled hydralazine content drinking water (30 mg/l) (between 84 and 98 days) and hydralazine (50 mg/l) (between 84 and 98 days) and reserpine (4 mg/l) (between 84 and 98 days) |
Velasquez MT, et al., Hypertension. 1997 Nov;30(5):1232-7. |
kidney mass |
male |
140 days-168 days |
8 |
|
|
1.83 |
g/kg |
0.31 |
0.88 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
101525 |
2601 |
SHR/N-cp |
plasma renin activity level |
standard diet (between 28 and 42 days) then controlled carbohydrate content diet (54 %) (between 140 and 154 days) |
Velasquez MT, et al., Hypertension. 1997 Nov;30(5):1232-7. |
renin activity |
male |
168 days-196 days |
8 |
|
|
11.0 |
ng/ml/h |
2.0 |
5.66 |
radioimmunoassay |
|
0.0 |
|
0 |
|
|
|
101532 |
2601 |
SHR/N-cp |
kidney sclerotic glomeruli count to total glomeruli count ratio |
standard diet (between 28 and 42 days) then controlled carbohydrate content diet (54 %) (between 140 and 154 days) then controlled hydralazine content drinking water (30 mg/l) (between 84 and 98 days) and hydralazine (50 mg/l) (between 84 and 98 days) and reserpine (4 mg/l) (between 84 and 98 days) |
Velasquez MT, et al., Hypertension. 1997 Nov;30(5):1232-7. |
kidney glomerulus integrity trait |
male |
140 days-168 days |
8 |
|
|
4.0 |
% |
1.0 |
2.83 |
ex vivo light microscopy with histochemistry |
|
0.0 |
|
0 |
|
|
|
101528 |
2601 |
MHS |
artery inner diameter |
standard diet (for 63 days) |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
kidney blood vessel morphology trait |
male |
63 days
| 10 |
|
|
14.5 |
um |
0.47 |
1.5 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
0 |
|
|
|
104227 |
2927 |
SD-Lepem1Sage-/- |
blood glucose level |
fasting (for 16 hours) then standard diet (for 1 hours) |
D'souza AM, et al., Endocrinology. 2014 Apr;155(4):1268-79. doi: 10.1210/en.2013-1523. Epub 2014 Jan 27. |
blood glucose amount |
female |
91 days
| 6 |
|
|
216.0 |
mg/dl |
23.4 |
57.32 |
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
104473 |
2949 |
SD-Lepem1Sage+/+ |
blood insulin level |
fasting (for 12 hours) then standard diet (for 1 hours) |
D'souza AM, et al., Endocrinology. 2014 Apr;155(4):1268-79. doi: 10.1210/en.2013-1523. Epub 2014 Jan 27. |
blood insulin amount |
male |
91 days
| 6 |
|
|
16.18 |
mU/l |
4.12 |
10.09 |
blood insulin analysis |
|
0.0 |
|
0 |
|
|
|
104475 |
2949 |
SD-Lepem1Sage-/- |
blood insulin level |
fasting (for 12 hours) then standard diet (for 1 hours) |
D'souza AM, et al., Endocrinology. 2014 Apr;155(4):1268-79. doi: 10.1210/en.2013-1523. Epub 2014 Jan 27. |
blood insulin amount |
female |
91 days
| 6 |
|
|
4727.1 |
mU/l |
1370.6 |
3357.27 |
blood insulin analysis |
|
0.0 |
|
0 |
|
|
|
104481 |
2949 |
SD-Abcc6em2Qlju+/- |
serum calcium level |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood calcium amount |
female |
60 days-180 days |
5 |
|
|
10.1 |
mg/dl |
0.2 |
0.45 |
colorimetry |
|
0.0 |
|
0 |
|
|
|
104639 |
2972 |
SD-Abcc6em2Qlju+/+ |
serum phosphate level |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood phosphate amount |
male |
60 days-180 days |
5 |
|
|
7.0 |
mg/dl |
0.3 |
0.67 |
liquid phase colorimetry |
|
0.0 |
|
0 |
|
|
|
104642 |
2972 |
SD-Abcc6em2Qlju-/- |
serum calcium to serum phosphate ratio |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood calcium amount |
female |
60 days-180 days |
5 |
|
|
1.73 |
null |
0.04 |
0.09 |
colorimetry |
|
0.0 |
|
0 |
|
|
|
104653 |
2972 |
SD-Abcc6em2Qlju+/+ |
serum phosphate level to plasma pyrophosphate level ratio |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood pyrophosphate amount |
female |
60 days-180 days |
5 |
|
|
558.9 |
null |
97.9 |
218.91 |
liquid phase colorimetry |
|
0.0 |
|
0 |
|
|
|
104661 |
2972 |
MHS |
serum creatinine level |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
blood creatinine amount |
male |
63 days
| 10 |
|
|
0.31 |
mg/dl |
0.0 |
0.02 |
creatinine analysis by Jaffe reaction with spectrophotometric readout |
|
0.0 |
|
0 |
|
|
|
104175 |
2927 |
Crl:WI |
creatinine clearance |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
glomerular filtration trait |
male |
63 days
| 10 |
|
|
1.1 |
ml/min |
0.01 |
0.04 |
creatinine analysis by Jaffe reaction with spectrophotometric readout |
|
0.0 |
|
0 |
|
|
|
104182 |
2927 |
MNS |
creatinine clearance |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
glomerular filtration trait |
male |
270 days
| 10 |
|
|
0.55 |
ml/min |
0.03 |
0.1 |
creatinine analysis by Jaffe reaction with spectrophotometric readout |
|
0.0 |
|
0 |
|
|
|
104183 |
2927 |
MHS |
urine total protein excretion rate |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
total urine protein amount |
male |
63 days
| 10 |
|
|
19.03 |
mg/d |
1.17 |
3.7 |
urine protein analysis |
|
0.0 |
|
0 |
|
|
|
104187 |
2927 |
Crl:WI |
urine total protein excretion rate |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
total urine protein amount |
male |
270 days
| 10 |
|
|
23.7 |
mg/d |
1.57 |
4.96 |
urine protein analysis |
|
0.0 |
|
0 |
|
|
|
104191 |
2927 |
Crl:WI |
creatinine clearance |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
glomerular filtration trait |
male |
270 days
| 10 |
|
|
0.94 |
ml/min |
0.02 |
0.05 |
creatinine analysis by Jaffe reaction with spectrophotometric readout |
|
0.0 |
|
0 |
|
|
|
104185 |
2927 |
MHS |
left kidney wet weight to body weight ratio |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
kidney mass |
male |
270 days
| 10 |
|
|
2.1 |
mg/g |
0.03 |
0.1 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
104208 |
2927 |
MHS |
artery tunica media width to artery inner diameter ratio |
standard diet (for 63 days) |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
kidney blood vessel morphology trait |
male |
63 days
| 10 |
|
|
0.83 |
null |
0.02 |
0.07 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
0 |
|
|
|
104215 |
2927 |
MHS |
artery diameter |
standard diet (for 270 days) |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
kidney blood vessel morphology trait |
male |
270 days
| 10 |
|
|
35.1 |
um |
0.7 |
2.2 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
0 |
|
|
|
104213 |
2927 |
MNS |
artery tunica media width to artery inner diameter ratio |
standard diet (for 270 days) |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
kidney blood vessel morphology trait |
male |
270 days
| 10 |
|
|
0.5 |
null |
0.02 |
0.06 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
0 |
|
|
|
104224 |
2927 |
MHS |
artery tunica media width to artery inner diameter ratio |
standard diet (for 270 days) |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
kidney blood vessel morphology trait |
male |
270 days
| 10 |
|
|
0.65 |
null |
0.01 |
0.02 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
0 |
|
|
|
104225 |
2927 |
MNS |
artery lumen to artery total diameter ratio |
standard diet (for 63 days) |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
kidney blood vessel morphology trait |
male |
63 days
| 10 |
|
|
49.8 |
% |
2.28 |
7.2 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
0 |
|
|
|
104230 |
2927 |
MNS |
artery lumen to artery total diameter ratio |
standard diet (for 270 days) |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
kidney blood vessel morphology trait |
male |
270 days
| 10 |
|
|
48.7 |
% |
0.95 |
3.0 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
0 |
|
|
|
104232 |
2927 |
MHS |
artery lumen to artery total diameter ratio |
standard diet (for 63 days) |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
kidney blood vessel morphology trait |
male |
63 days
| 10 |
|
|
40.2 |
% |
0.32 |
1.0 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
0 |
|
|
|
104231 |
2927 |
MWF/Ztm |
systolic blood pressure |
standard diet |
Iordache BE, etal., J Am Soc Nephrol. 1994 Dec;5(6):1378-84. |
arterial blood pressure trait |
male |
252 days-253 days |
5 |
|
|
170.0 |
mmHg |
3.58 |
8.0 |
tail cuff plethysmography |
tail |
0.0 |
|
0 |
|
|
|
109144 |
3136 |
MWF/Fub |
systolic blood pressure |
standard diet |
Kreutz R, etal., J Hypertens. 2000 Jun;18(6):777-82. doi: 10.1097/00004872-200018060-00017. |
arterial blood pressure trait |
male |
100 days-103 days |
8 |
|
|
165.0 |
mmHg |
2.0 |
5.66 |
tail cuff plethysmography |
tail |
0.0 |
|
0 |
|
|
|
109021 |
3134 |
MWF/Ztm |
mesangium volume per glomerulus |
standard diet |
Iordache BE, etal., J Am Soc Nephrol. 1994 Dec;5(6):1378-84. |
kidney glomerulus morphology trait |
male |
131 days
| 6 |
Pc/Pr, number of grid points falling into the component (Pc: mesangial cells and matrix) and the number of points falling into the reference area (Pr. i.e., the glomerular tuft |
|
0.14 |
x 10E-6 um3 |
0.02 |
0.04 |
ex vivo electron microscopy with digital image analysis |
renal glomerulus |
0.0 |
|
0 |
|
|
mesangium volume per glomerulus (CMO:0003716) |
109168 |
3136 |
MWF/Ztm |
podocyte foot process height |
standard diet |
Iordache BE, etal., J Am Soc Nephrol. 1994 Dec;5(6):1378-84. |
podocyte morphology trait |
male |
131 days
| 6 |
|
|
378.0 |
nm |
34.29 |
84.0 |
ex vivo electron microscopy with digital image analysis |
|
0.0 |
|
0 |
|
|
|
109187 |
3136 |
MWF/Ztm |
podocyte slit width |
standard diet |
Iordache BE, etal., J Am Soc Nephrol. 1994 Dec;5(6):1378-84. |
podocyte morphology trait |
male |
252 days-253 days |
5 |
|
|
37.0 |
nm |
0.89 |
2.0 |
ex vivo electron microscopy with digital image analysis |
|
0.0 |
|
0 |
|
|
|
109191 |
3136 |
Crl:WI |
urine total protein excretion rate |
standard diet |
Remuzzi A, etal., Kidney Int. 1988 Oct;34(4):481-6. doi: 10.1038/ki.1988.206. |
urine protein amount |
both |
147 days
| 12 |
|
|
28.0 |
mg/d |
2.89 |
10.0 |
Bradford protein assay |
|
0.0 |
|
0 |
|
|
|
109204 |
3138 |
MWF/Ztm |
urine total protein excretion rate |
standard diet |
Remuzzi A, etal., Am J Kidney Dis. 1999 Oct;34(4):626-32. doi: 10.1016/S0272-6386(99)70385-9. |
total urine protein amount |
male |
140 days
| 10 |
|
|
165.0 |
mg/d |
18.02 |
57.0 |
Bradford protein assay |
|
0.0 |
|
0 |
|
|
|
109979 |
3162 |
MWF/Ztm |
right kidney wet weight |
standard diet |
Remuzzi A, etal., Am J Kidney Dis. 1999 Oct;34(4):626-32. doi: 10.1016/S0272-6386(99)70385-9. |
kidney mass |
male |
210 days
| 10 |
|
|
1.39 |
g |
0.03 |
0.09 |
post excision weight measurement |
right kidney |
0.0 |
|
0 |
|
|
|
109983 |
3162 |
MWF/Ztm |
urine total protein excretion rate |
standard diet |
Iordache BE, etal., J Am Soc Nephrol. 1994 Dec;5(6):1378-84. |
total urine protein amount |
male |
131 days
| 6 |
|
|
162.0 |
mg/d |
4.9 |
12.0 |
Bradford protein assay |
|
0.0 |
|
0 |
|
|
|
109146 |
3136 |
SHRSP/A3NCrl |
partial pressure of brain white matter oxygen |
sham surgical control condition then standard diet |
Weaver J, etal., J Cereb Blood Flow Metab. 2014 May;34(5):890-6. doi: 10.1038/jcbfm.2014.35. Epub 2014 Feb 19. |
brain oxygen amount |
male |
84 days
| 8 |
|
|
41.8 |
mmHg |
2.5 |
7.07 |
electron paramagnetic resonance oximetry |
white matter |
40.0 |
|
0 |
|
5 scans x 40 seconds |
partial pressure of brain white matter oxygen (CMO:0003626) |
107319 |
3080 |
SHRSP/A3NCrl |
partial pressure of brain white matter oxygen |
sham surgical control condition then standard diet |
Weaver J, etal., J Cereb Blood Flow Metab. 2014 May;34(5):890-6. doi: 10.1038/jcbfm.2014.35. Epub 2014 Feb 19. |
brain oxygen amount |
male |
91 days
| 8 |
|
|
19.7 |
mmHg |
3.4 |
9.62 |
electron paramagnetic resonance oximetry |
white matter |
40.0 |
|
0 |
|
5 scans x 40 seconds |
partial pressure of brain white matter oxygen (CMO:0003626) |
107320 |
3080 |
SHRSP/A3NCrl |
partial pressure of brain white matter oxygen |
sham surgical control condition then standard diet |
Weaver J, etal., J Cereb Blood Flow Metab. 2014 May;34(5):890-6. doi: 10.1038/jcbfm.2014.35. Epub 2014 Feb 19. |
brain oxygen amount |
male |
112 days
| 8 |
|
|
15.4 |
mmHg |
3.8 |
10.75 |
electron paramagnetic resonance oximetry |
white matter |
40.0 |
|
0 |
|
5 scans x 40 seconds |
partial pressure of brain white matter oxygen (CMO:0003626) |
107324 |
3080 |
SHRSP/A3NCrl |
partial pressure of brain white matter oxygen |
sham surgical control condition then standard diet |
Weaver J, etal., J Cereb Blood Flow Metab. 2014 May;34(5):890-6. doi: 10.1038/jcbfm.2014.35. Epub 2014 Feb 19. |
brain oxygen amount |
male |
105 days
| 8 |
|
|
16.8 |
mmHg |
3.7 |
10.47 |
electron paramagnetic resonance oximetry |
white matter |
40.0 |
|
0 |
|
5 scans x 40 seconds |
partial pressure of brain white matter oxygen (CMO:0003626) |
107323 |
3080 |
SHRSP/A3NCrl |
partial pressure of brain white matter oxygen |
standard diet |
Weaver J, etal., J Cereb Blood Flow Metab. 2014 May;34(5):890-6. doi: 10.1038/jcbfm.2014.35. Epub 2014 Feb 19. |
brain oxygen amount |
male |
84 days
| 6 |
|
|
34.1 |
mmHg |
2.7 |
6.61 |
electron paramagnetic resonance oximetry |
white matter |
40.0 |
|
0 |
|
5 scans x 40 seconds |
vascular cognitive impairment |
107314 |
3080 |
MWF/Fub |
systolic blood pressure |
standard diet |
Kreutz R, etal., J Hypertens. 2000 Jun;18(6):777-82. doi: 10.1097/00004872-200018060-00017. |
arterial blood pressure trait |
female |
100 days-103 days |
8 |
|
|
156.0 |
mmHg |
3.0 |
8.49 |
tail cuff plethysmography |
tail |
0.0 |
|
0 |
|
|
|
109020 |
3134 |
SD-Ldlrem1Sage |
plasma albumin level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood albumin amount |
male |
448 days
| 8 |
|
|
0.35 |
g/l |
0.01 |
0.03 |
automated plasma albumin analysis |
|
0.0 |
|
0 |
|
|
|
138277 |
3201 |
Hsd:SD |
plasma total protein level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood total protein amount |
male |
448 days
| 9 |
|
|
65.2 |
mg/ml |
2.0 |
6.0 |
automated plasma total protein analysis |
|
0.0 |
|
0 |
|
|
|
138280 |
3201 |
Hsd:SD |
plasma aspartate aminotransferase activity level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood aspartate transaminase amount |
male |
448 days
| 9 |
|
|
159.0 |
U/l |
16.0 |
48.0 |
automated plasma aspartate aminotransferase activity assay |
|
0.0 |
|
0 |
|
|
|
138289 |
3201 |
Hsd:SD |
blood very low density lipoprotein particle diameter |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood VLDL particle size |
male |
448 days
| 9 |
|
|
38.0 |
nm |
1.5 |
4.5 |
nuclear magnetic resonance spectroscopy |
|
0.0 |
|
0 |
|
|
|
138330 |
3201 |
SD-Ldlrem1Sage |
blood interleukin-4 level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood interleukin-4 amount |
male |
448 days
| 8 |
|
|
11.0 |
pg/ml |
2.0 |
5.66 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
138361 |
3201 |
SD-Ldlrem1Sage |
blood low density lipoprotein particle diameter |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood LDL particle size |
male |
448 days
| 8 |
|
|
22.9 |
nm |
0.1 |
0.28 |
nuclear magnetic resonance spectroscopy |
|
0.0 |
|
0 |
|
|
|
138335 |
3201 |
SD-Ldlrem1Sage |
blood high density lipoprotein particle diameter |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood HDL particle size |
male |
448 days
| 8 |
|
|
13.0 |
nm |
0.1 |
0.28 |
nuclear magnetic resonance spectroscopy |
|
0.0 |
|
0 |
|
|
|
138339 |
3201 |
Hsd:SD |
plasma plasminogen activator inhibitor 1 level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood plasminogen activator inhibitor 1 amount |
male |
448 days
| 9 |
|
|
9.31 |
ng/ml |
0.79 |
2.37 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
138306 |
3201 |
SD-Ldlrem1Sage |
blood fibrinogen level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
fibrin formation trait |
male |
448 days
| 8 |
|
|
2.87 |
mg/ml |
0.17 |
0.47 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
138311 |
3201 |
Hsd:SD |
plasma free fatty acids level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood free fatty acid amount |
male |
448 days
| 9 |
|
|
0.52 |
mmol/l |
0.04 |
0.12 |
plasma free fatty acid analysis |
|
0.0 |
|
0 |
|
|
|
138322 |
3201 |
Hsd:SD |
plasma chylomicron and VLDL cholesterol level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood cholesterol amount |
male |
448 days
| 9 |
|
|
10.0 |
mg/dl |
1.0 |
3.0 |
blood cholesterol analysis |
|
0.0 |
|
0 |
|
|
|
138460 |
3201 |
Crl:CD(SD) |
plasma alanine aminotransferase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood alanine transaminase amount |
male |
78 days
| 19 |
|
|
35.0 |
U/l |
1.49 |
6.5 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85429 |
1604 |
Crl:CD(SD) |
food intake rate |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
105 days
| 19 |
|
|
17.2 |
g/d |
0.6 |
2.6 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85293 |
1604 |
Crl:CD(SD) |
food intake weight to body weight ratio |
standard diet then acetaminophen (300 mg/kg) (for 77 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
147 days
| 8 |
|
|
4.09 |
g/d/100g |
0.45 |
1.28 |
unspecified method |
|
0.0 |
|
0 |
|
|
on days 74-77 |
85507 |
1604 |
Crl:CD(SD) |
food intake weight to body weight ratio |
standard diet then acetaminophen (500 mg/kg) (for 56 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
126 days
| 8 |
|
|
4.53 |
g/d/100g |
0.13 |
0.36 |
unspecified method |
|
0.0 |
|
0 |
|
|
on days 53-56 |
85502 |
1604 |
WI |
body weight |
controlled in utero environment (for 21 days) and standard diet (100 % of calories) (for 21 days) |
Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10. |
body mass |
male |
1 days
| 21 |
|
|
8.4 |
g |
0.8 |
3.67 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
101051 |
2563 |
SD-Abcc6em2Qlju+/+ |
serum calcium to serum phosphate ratio |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood calcium amount |
female |
60 days-180 days |
5 |
|
|
1.61 |
null |
0.06 |
0.13 |
colorimetry |
|
0.0 |
|
0 |
|
|
|
104649 |
2972 |
SD-Abcc6em2Qlju-/- |
serum phosphate level |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood phosphate amount |
male |
60 days-180 days |
5 |
|
|
7.1 |
mg/dl |
0.5 |
1.12 |
liquid phase colorimetry |
|
0.0 |
|
0 |
|
|
|
104646 |
2972 |
MNS |
timed urine volume |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
urine output |
male |
63 days
| 10 |
|
|
14.2 |
ml/d |
1.66 |
5.26 |
urine volume measurement method |
|
0.0 |
|
0 |
|
|
|
104168 |
2927 |
MHS |
body weight |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
body mass |
male |
63 days
| 10 |
|
|
245.4 |
g |
3.98 |
12.6 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
104193 |
2927 |
Crl:CD(SD) |
plasma pyruvate level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood pyruvate amount |
male |
78 days
| 19 |
|
|
0.41 |
mg/dl |
0.03 |
0.11 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85340 |
1604 |
Crl:CD(SD) |
plasma glucose level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glucose amount |
male |
105 days
| 19 |
|
|
129.0 |
mg/dl |
1.38 |
6.0 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85328 |
1604 |
Crl:CD(SD) |
plasma lactate level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood lactate amount |
male |
91 days
| 19 |
|
|
25.2 |
mg/dl |
2.09 |
9.1 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85359 |
1604 |
Crl:CD(SD) |
plasma pyruvate level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood pyruvate amount |
male |
105 days
| 19 |
|
|
0.81 |
mg/dl |
0.06 |
0.27 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85345 |
1604 |
Crl:CD(SD) |
urine creatine excretion rate |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
urine creatine amount |
male |
134 days
| 19 |
|
|
2.0 |
umol/d |
0.13 |
0.57 |
liquid chromatography-mass spectrometry |
|
0.0 |
|
0 |
|
|
|
85383 |
1604 |
Crl:CD(SD) |
plasma aspartate aminotransferase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood aspartate transaminase amount |
male |
147 days
| 19 |
|
|
55.4 |
U/l |
2.25 |
9.8 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85422 |
1604 |
Crl:CD(SD) |
plasma alanine aminotransferase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood alanine transaminase amount |
male |
168 days
| 19 |
|
|
33.2 |
U/l |
1.1 |
4.8 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85441 |
1604 |
Crl:CD(SD) |
plasma glutamate dehydrogenase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glutamate dehydrogenase amount |
male |
168 days
| 19 |
|
|
12.8 |
U/l |
0.69 |
3.0 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85457 |
1604 |
WKY |
plasma very low density lipoprotein cholesterol level |
standard diet (for 20 days) |
Orolin J, et al., Food Chem Toxicol. 2009 Oct;47(10):2624-30. doi: 10.1016/j.fct.2009.07.022. Epub 2009 Jul 25. |
blood VLDL cholesterol amount |
male |
0 days
| 7 |
|
|
2.7 |
mg/dl |
0.39 |
1.02 |
enzymatic cholesterol assay |
|
0.0 |
|
0 |
|
|
|
98906 |
2178 |
Crl:CD(SD) |
food intake rate |
standard diet then acetaminophen (300 mg/kg) (for 35 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
105 days
| 8 |
|
|
24.5 |
g/d |
0.57 |
1.6 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85465 |
1604 |
Crl:CD(SD) |
food intake rate |
standard diet then acetaminophen (500 mg/kg) (for 77 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
147 days
| 8 |
|
|
24.5 |
g/d |
0.32 |
0.9 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85478 |
1604 |
Crl:CD(SD) |
food intake rate |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
147 days
| 19 |
|
|
19.4 |
g/d |
0.87 |
3.8 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85297 |
1604 |
Crl:CD(SD) |
body weight |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
168 days
| 19 |
|
|
444.0 |
g |
6.65 |
29.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85321 |
1604 |
Crl:CD(SD) |
plasma pyruvate level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood pyruvate amount |
male |
78 days
| 19 |
|
|
0.69 |
mg/dl |
0.15 |
0.64 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85341 |
1604 |
Crl:CD(SD) |
body weight |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
126 days
| 19 |
|
|
401.0 |
g |
4.82 |
21.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85317 |
1604 |
Crl:CD(SD) |
plasma lactate level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood lactate amount |
male |
119 days
| 19 |
|
|
19.8 |
mg/dl |
0.87 |
3.8 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85362 |
1604 |
Crl:CD(SD) |
urine creatinine excretion rate |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
urine creatinine amount |
male |
169 days
| 19 |
|
|
14.95 |
mg/d |
0.54 |
2.38 |
liquid chromatography-mass spectrometry |
|
0.0 |
|
0 |
|
|
|
85392 |
1604 |
Crl:CD(SD) |
liver oxidized glutathione level to liver weight ratio |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
liver glutathione amount |
male |
170 days
| 19 |
|
|
0.21 |
umol/g |
0.01 |
0.03 |
reduced glutathione/oxidized glutathione enzyme recycling assay |
|
0.0 |
|
0 |
|
enzyme recycling method |
oxidized liver glutathione level to liver weight ratio |
85408 |
1604 |
Crl:CD(SD) |
plasma glutamate dehydrogenase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glutamate dehydrogenase amount |
male |
78 days
| 19 |
|
|
17.9 |
U/l |
1.61 |
7.0 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85445 |
1604 |
Crl:CD(SD) |
food intake rate |
standard diet then acetaminophen (300 mg/kg) (for 98 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
168 days
| 8 |
|
|
23.4 |
g/d |
0.42 |
1.2 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85483 |
1604 |
Crl:CD(SD) |
food intake rate |
standard diet and restricted feeding (4 h) then acetaminophen (300 mg/kg) (for 35 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
105 days
| 8 |
|
|
18.2 |
g/d |
1.13 |
3.2 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85468 |
1604 |
Crl:CD(SD) |
food intake rate |
standard diet then acetaminophen (500 mg/kg) (for 98 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
168 days
| 8 |
|
|
22.8 |
g/d |
0.71 |
2.0 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85484 |
1604 |
Crl:CD(SD) |
food intake weight to body weight ratio |
standard diet then acetaminophen (300 mg/kg) (for 98 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
168 days
| 8 |
|
|
4.05 |
g/d/100g |
0.08 |
0.24 |
unspecified method |
|
0.0 |
|
0 |
|
|
on days 95-98 |
85513 |
1604 |
Crl:CD(SD) |
body weight |
standard diet then acetaminophen (500 mg/kg) (for 56 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
126 days
| 8 |
|
|
516.0 |
g |
12.73 |
36.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85538 |
1604 |
Crl:CD(SD) |
plasma acetaminophen level area under curve |
standard diet then acetaminophen (300 mg/kg) (for 99 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood acetaminophen amount |
male |
170 days
| 8 |
|
|
662.2 |
(ug/ml) x h |
28.35 |
80.2 |
high-performance liquid chromatography |
|
0.0 |
acetaminophen dosing |
1140 |
min |
4-19 hr dosing |
4-19 hr dosing |
85586 |
1604 |
Crl:CD(SD) |
liver reduced glutathione level to liver weight ratio |
standard diet and restricted feeding (4 h) (for 114 days) then acetaminophen (500 mg/kg) (for 99 days) then fasting (for 20 hours) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
liver glutathione amount |
male |
170 days
| 8 |
|
|
5.19 |
umol/g |
0.24 |
0.69 |
reduced glutathione/oxidized glutathione enzyme recycling assay |
|
0.0 |
|
0 |
|
enzyme recycling method |
|
85571 |
1604 |
Crl:CD(SD) |
plasma pyruvate level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood pyruvate amount |
male |
119 days
| 19 |
|
|
0.61 |
mg/dl |
0.02 |
0.08 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85346 |
1604 |
Crl:CD(SD) |
plasma glucose level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glucose amount |
male |
168 days
| 19 |
|
|
128.0 |
mg/dl |
1.84 |
8.0 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85337 |
1604 |
Crl:CD(SD) |
food intake weight to body weight ratio |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
147 days
| 19 |
|
|
4.18 |
g/d/100g |
0.19 |
0.84 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85307 |
1604 |
Crl:CD(SD) |
plasma pyruvate level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood pyruvate amount |
male |
91 days
| 19 |
|
|
1.0 |
mg/dl |
0.08 |
0.35 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85343 |
1604 |
Crl:CD(SD) |
plasma pyruvate level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood pyruvate amount |
male |
105 days
| 19 |
|
|
0.49 |
mg/dl |
0.02 |
0.1 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85344 |
1604 |
Crl:CD(SD) |
plasma pyruvate level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood pyruvate amount |
male |
147 days
| 19 |
|
|
0.47 |
mg/dl |
0.05 |
0.21 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85350 |
1604 |
Crl:CD(SD) |
plasma creatinine level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood creatinine amount |
male |
133 days
| 19 |
|
|
0.41 |
mg/dl |
0.01 |
0.04 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85375 |
1604 |
Crl:CD(SD) |
urine taurine excretion rate |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
urine taurine amount |
male |
134 days
| 19 |
|
|
141.5 |
umol/d |
12.76 |
55.6 |
liquid chromatography-mass spectrometry |
|
0.0 |
|
0 |
|
|
|
85398 |
1604 |
Crl:CD(SD) |
plasma aspartate aminotransferase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood aspartate transaminase amount |
male |
91 days
| 19 |
|
|
56.3 |
U/l |
1.12 |
4.9 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85414 |
1604 |
Crl:CD(SD) |
plasma aspartate aminotransferase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood aspartate transaminase amount |
male |
133 days
| 19 |
|
|
57.6 |
U/l |
1.58 |
6.9 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85421 |
1604 |
Crl:CD(SD) |
plasma alanine aminotransferase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood alanine transaminase amount |
male |
78 days
| 19 |
|
|
33.9 |
U/l |
0.83 |
3.6 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85428 |
1604 |
Crl:CD(SD) |
food intake rate |
standard diet then acetaminophen (300 mg/kg) (for 77 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
147 days
| 8 |
|
|
24.3 |
g/d |
0.32 |
0.9 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85477 |
1604 |
Crl:CD(SD) |
liver wet weight |
standard diet and restricted feeding (4 h) (for 114 days) then acetaminophen (300 mg/kg) (for 99 days) then fasting (for 20 hours) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
liver mass |
male |
170 days
| 8 |
|
|
12.2 |
g |
0.77 |
2.17 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85558 |
1604 |
Crl:CD(SD) |
plasma alanine aminotransferase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood alanine transaminase amount |
male |
70 days
| 19 |
|
|
35.3 |
U/l |
1.03 |
4.5 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85427 |
1604 |
Crl:CD(SD) |
plasma aspartate aminotransferase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood aspartate transaminase amount |
male |
147 days
| 19 |
|
|
54.3 |
U/l |
1.26 |
5.5 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85423 |
1604 |
Crl:CD(SD) |
liver oxidized glutathione level to liver weight ratio |
standard diet then acetaminophen (300 mg/kg) (for 99 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
liver glutathione amount |
male |
170 days
| 8 |
|
|
0.24 |
umol/g |
0.01 |
0.02 |
reduced glutathione/oxidized glutathione enzyme recycling assay |
|
0.0 |
|
0 |
|
enzyme recycling method |
reduced liver glutathione level to liver weight ratio |
85573 |
1604 |
Jcl:WI |
body weight |
standard diet |
Radosinska J, et al., Physiol Res. 2015;64(6):795-806. Epub 2015 Oct 8. |
body mass |
male |
84 days
| 8 |
|
|
432.0 |
g |
10.25 |
29.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
103055 |
2785 |
GK/Jcl |
body weight |
standard diet |
Radosinska J, et al., Physiol Res. 2015;64(6):795-806. Epub 2015 Oct 8. |
body mass |
male |
84 days
| 8 |
|
|
353.0 |
g |
7.07 |
20.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
103057 |
2785 |
GK/Jcl |
heart weight |
standard diet |
Radosinska J, et al., Physiol Res. 2015;64(6):795-806. Epub 2015 Oct 8. |
heart mass |
male |
84 days
| 8 |
|
|
0.98 |
g |
0.01 |
0.04 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
103061 |
2785 |
Jcl:WI |
heart left ventricle weight |
standard diet |
Radosinska J, et al., Physiol Res. 2015;64(6):795-806. Epub 2015 Oct 8. |
heart left ventricle mass |
male |
84 days
| 8 |
|
|
0.81 |
g |
0.03 |
0.08 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
103063 |
2785 |
GK/Jcl |
blood triglyceride level |
standard diet |
Radosinska J, et al., Physiol Res. 2015;64(6):795-806. Epub 2015 Oct 8. |
blood triglyceride amount |
male |
84 days
| 8 |
|
|
107.08 |
mg/dl |
9.07 |
25.66 |
blood triglyceride analysis |
|
0.0 |
|
0 |
|
|
|
103077 |
2785 |
HTG |
liver triglyceride level |
standard diet (for 20 days) |
Orolin J, et al., Food Chem Toxicol. 2009 Oct;47(10):2624-30. doi: 10.1016/j.fct.2009.07.022. Epub 2009 Jul 25. |
liver triglyceride amount |
male |
0 days
| 7 |
|
|
10.17 |
mg/g |
1.14 |
3.02 |
enzymatic triglyceride assay |
|
0.0 |
|
0 |
|
|
|
98900 |
2178 |
SR/Hsd |
creatinine clearance |
standard diet |
Wu F, et al., Int J Hypertens. 2016;2016:9146870. doi: 10.1155/2016/9146870. Epub 2016 Dec 19. |
glomerular filtration trait |
male |
49 days
| 8 |
|
|
3.5 |
ml/min |
0.07 |
0.2 |
urine creatinine analysis |
|
0.0 |
|
0 |
|
|
|
102287 |
2683 |
WI |
body weight |
controlled in utero environment (for 21 days) and standard diet (50 % of calories) (for 21 days) |
Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10. |
body mass |
male |
1 days
| 35 |
|
|
4.7 |
g |
0.07 |
0.41 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
101052 |
2563 |
SHR/N-cp |
serum glucose level |
standard diet (between 28 and 42 days) then controlled carbohydrate content diet (54 %) (between 84 and 98 days) then perindopril (0.25-0.5 mg/kg/d) (between 28 and 42 days) |
Velasquez MT, et al., Hypertension. 1997 Nov;30(5):1232-7. |
blood glucose amount |
male |
112 days-140 days |
8 |
|
|
192.39 |
mg/dl |
29.04 |
82.14 |
serum glucose analysis |
|
0.0 |
|
0 |
|
|
|
101503 |
2601 |
SHR/N-cp |
kidney sclerotic glomeruli count to total glomeruli count ratio |
standard diet (between 28 and 42 days) then controlled carbohydrate content diet (54 %) (between 140 and 154 days) then perindopril (0.25-0.5 mg/kg/d) (between 84 and 98 days) |
Velasquez MT, et al., Hypertension. 1997 Nov;30(5):1232-7. |
kidney glomerulus integrity trait |
male |
168 days-196 days |
8 |
|
|
9.0 |
% |
4.0 |
11.31 |
ex vivo light microscopy with histochemistry |
|
0.0 |
|
0 |
|
|
|
101527 |
2601 |
WI |
creatinine clearance to body weight ratio |
controlled in utero environment (for 21 days) and standard diet (50 % of calories) (for 21 days) |
Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10. |
glomerular filtration trait |
male |
102 days
| 6 |
|
|
0.48 |
ml/min/100g |
0.08 |
0.18 |
serum creatinine analysis |
|
0.0 |
|
0 |
|
|
|
101066 |
2563 |
WI |
serum urea nitrogen level |
controlled in utero environment (for 21 days) and standard diet (50 % of calories) (for 21 days) |
Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10. |
blood urea nitrogen amount |
male |
102 days
| 6 |
|
|
45.33 |
mg/dl |
4.7 |
11.51 |
serum urea nitrogen analysis |
|
0.0 |
|
0 |
|
|
|
101068 |
2563 |
WI |
glucose disappearance constant |
controlled in utero environment (for 21 days) and standard diet (100 % of calories) (for 21 days) |
Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10. |
blood glucose amount |
male |
102 days
| 6 |
|
|
2.88 |
null |
0.3 |
0.73 |
serum glucose analysis |
|
0.0 |
|
0 |
|
|
|
101074 |
2563 |
WI |
plasma total cholesterol level |
controlled in utero environment (for 21 days) and standard diet (50 % of calories) (for 21 days) |
Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10. |
blood cholesterol amount |
male |
102 days
| 6 |
|
|
42.0 |
mg/dl |
3.87 |
9.48 |
plasma total cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
101072 |
2563 |
MHS |
artery tunica media width to artery inner diameter ratio |
standard diet (for 270 days) |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
kidney blood vessel morphology trait |
male |
270 days
| 10 |
|
|
0.89 |
null |
0.03 |
0.09 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
0 |
|
|
|
104217 |
2927 |
SD-Lepem1Sage+/+ |
blood glucose level |
fasting (for 16 hours) then standard diet (for 1 hours) |
D'souza AM, et al., Endocrinology. 2014 Apr;155(4):1268-79. doi: 10.1210/en.2013-1523. Epub 2014 Jan 27. |
blood glucose amount |
female |
91 days
| 6 |
|
|
142.56 |
mg/dl |
12.42 |
30.42 |
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
104472 |
2949 |
SD-Lepem1Sage-/- |
blood glucose level |
fasting (for 16 hours) then standard diet (for 1 hours) |
D'souza AM, et al., Endocrinology. 2014 Apr;155(4):1268-79. doi: 10.1210/en.2013-1523. Epub 2014 Jan 27. |
blood glucose amount |
male |
91 days
| 6 |
|
|
185.76 |
mg/dl |
16.74 |
41.0 |
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
104471 |
2949 |
SD-Lepem1Sage+/+ |
blood insulin level |
fasting (for 12 hours) then standard diet (for 1 hours) |
D'souza AM, et al., Endocrinology. 2014 Apr;155(4):1268-79. doi: 10.1210/en.2013-1523. Epub 2014 Jan 27. |
blood insulin amount |
female |
91 days
| 6 |
|
|
17.35 |
mU/l |
3.82 |
9.37 |
blood insulin analysis |
|
0.0 |
|
0 |
|
|
|
104479 |
2949 |
SD-Abcc6em2Qlju-/- |
serum calcium level |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood calcium amount |
female |
60 days-180 days |
5 |
|
|
10.2 |
mg/dl |
0.3 |
0.67 |
colorimetry |
|
0.0 |
|
0 |
|
|
|
104641 |
2972 |
SD-Abcc6em2Qlju+/+ |
serum calcium level |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood calcium amount |
male |
60 days-180 days |
5 |
|
|
10.8 |
mg/dl |
0.4 |
0.89 |
colorimetry |
|
0.0 |
|
0 |
|
|
|
104636 |
2972 |
MNS |
creatinine clearance |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
glomerular filtration trait |
male |
63 days
| 10 |
|
|
1.09 |
ml/min |
0.01 |
0.03 |
creatinine analysis by Jaffe reaction with spectrophotometric readout |
|
0.0 |
|
0 |
|
|
|
104180 |
2927 |
Crl:WI |
left kidney wet weight |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
kidney mass |
male |
63 days
| 10 |
|
|
0.99 |
g |
0.02 |
0.06 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
104200 |
2927 |
Crl:WI |
left kidney wet weight |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
kidney mass |
male |
270 days
| 10 |
|
|
1.57 |
g |
0.07 |
0.22 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
104203 |
2927 |
MHS |
left kidney wet weight to body weight ratio |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
kidney mass |
male |
63 days
| 10 |
|
|
3.1 |
mg/g |
0.03 |
0.1 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
104205 |
2927 |
MNS |
artery diameter |
standard diet (for 270 days) |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
kidney blood vessel morphology trait |
male |
270 days
| 10 |
|
|
35.9 |
um |
1.33 |
4.2 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
0 |
|
|
|
104212 |
2927 |
MNS |
artery tunica media width to artery inner diameter ratio |
standard diet (for 63 days) |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
kidney blood vessel morphology trait |
male |
63 days
| 10 |
|
|
0.5 |
null |
0.02 |
0.07 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
0 |
|
|
|
104222 |
2927 |
MWF/Ztm |
systolic blood pressure |
standard diet |
Iordache BE, etal., J Am Soc Nephrol. 1994 Dec;5(6):1378-84. |
arterial blood pressure trait |
male |
131 days
| 6 |
|
|
151.0 |
mmHg |
2.86 |
7.0 |
tail cuff plethysmography |
tail |
0.0 |
|
0 |
|
|
|
109143 |
3136 |
MWF/Ztm |
body weight |
standard diet |
Remuzzi A, etal., Kidney Int. 1988 Oct;34(4):481-6. doi: 10.1038/ki.1988.206. |
body mass |
male |
105 days-147 days |
8 |
|
|
317.0 |
g |
18.74 |
53.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
109197 |
3138 |
MWF/Ztm |
total pericapillary slit length |
standard diet |
Iordache BE, etal., J Am Soc Nephrol. 1994 Dec;5(6):1378-84. |
podocyte morphology trait |
male |
131 days
| 6 |
|
|
647.43 |
mm |
33.65 |
82.42 |
ex vivo electron microscopy with digital image analysis |
|
0.0 |
|
0 |
|
|
|
109179 |
3136 |
MWF/Ztm |
mean length density of glomerular capillaries |
standard diet |
Iordache BE, etal., J Am Soc Nephrol. 1994 Dec;5(6):1378-84. |
glomerular capillary morphology trait |
male |
131 days
| 6 |
2xNcap/k2xPr, Ncap is number of capillary profiles, k2 is ratio between the distance (In micrometers) of two adjacent grid points and the magnification, Pr is grid points falling Into the glomerular tuft |
|
11.8 |
REQUEST NEW VALUE |
0.53 |
1.3 |
ex vivo electron microscopy with digital image analysis |
renal glomerulus |
0.0 |
|
0 |
|
|
|
109175 |
3136 |
MWF/Ztm |
podocyte foot process width |
standard diet |
Iordache BE, etal., J Am Soc Nephrol. 1994 Dec;5(6):1378-84. |
podocyte morphology trait |
male |
252 days-253 days |
5 |
|
|
219.0 |
nm |
6.71 |
15.0 |
ex vivo electron microscopy with digital image analysis |
|
0.0 |
|
0 |
|
|
|
109192 |
3136 |
MWF/Ztm |
podocyte foot process height |
standard diet |
Iordache BE, etal., J Am Soc Nephrol. 1994 Dec;5(6):1378-84. |
podocyte morphology trait |
male |
252 days-253 days |
5 |
|
|
306.0 |
nm |
11.63 |
26.0 |
ex vivo electron microscopy with digital image analysis |
|
0.0 |
|
0 |
|
|
|
109193 |
3136 |
MWF/Ztm |
body weight |
standard diet |
Remuzzi A, etal., Am J Kidney Dis. 1999 Oct;34(4):626-32. doi: 10.1016/S0272-6386(99)70385-9. |
body mass |
male |
210 days
| 10 |
|
|
423.0 |
g |
5.38 |
17.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
109975 |
3162 |
LEW/Mol |
kidney weight |
standard diet |
Kreutz R, etal., J Hypertens. 2000 Jun;18(6):777-82. doi: 10.1097/00004872-200018060-00017. |
kidney mass |
female |
104 days
| 8 |
|
|
0.72 |
g |
0.01 |
0.03 |
post excision weight measurement |
kidney |
0.0 |
|
0 |
|
|
|
109004 |
3134 |
Crl:WI |
urine total protein excretion rate |
standard diet |
Remuzzi A, etal., Kidney Int. 1988 Oct;34(4):481-6. doi: 10.1038/ki.1988.206. |
urine protein amount |
both |
49 days
| 12 |
|
|
10.0 |
mg/d |
0.87 |
3.0 |
Bradford protein assay |
|
0.0 |
|
0 |
|
|
|
109203 |
3138 |
MWF/Ztm |
urine total protein excretion rate |
standard diet |
Remuzzi A, etal., Am J Kidney Dis. 1999 Oct;34(4):626-32. doi: 10.1016/S0272-6386(99)70385-9. |
total urine protein amount |
male |
140 days
| 7 |
|
|
172.0 |
mg/d |
29.86 |
79.0 |
Bradford protein assay |
|
0.0 |
|
0 |
|
|
|
109980 |
3162 |
MWF/Ztm |
kidney sclerotic glomeruli count to total glomeruli count ratio |
standard diet |
Remuzzi A, etal., Am J Kidney Dis. 1999 Oct;34(4):626-32. doi: 10.1016/S0272-6386(99)70385-9. |
kidney glomerulus integrity trait |
male |
140 days
| 8 |
|
median |
2.2 |
% |
|
|
ex vivo light microscopy with histochemistry |
left kidney |
0.0 |
|
0 |
|
|
|
109985 |
3162 |
MWF/Ztm |
urine total protein excretion rate |
standard diet |
Iordache BE, etal., J Am Soc Nephrol. 1994 Dec;5(6):1378-84. |
total urine protein amount |
male |
252 days-253 days |
5 |
|
|
309.0 |
mg/d |
26.83 |
60.0 |
Bradford protein assay |
|
0.0 |
|
0 |
|
|
|
109147 |
3136 |
SHRSP/A3NCrl |
partial pressure of brain white matter oxygen |
sham surgical control condition then standard diet |
Weaver J, etal., J Cereb Blood Flow Metab. 2014 May;34(5):890-6. doi: 10.1038/jcbfm.2014.35. Epub 2014 Feb 19. |
brain oxygen amount |
male |
98 days
| 8 |
|
|
18.0 |
mmHg |
3.4 |
9.62 |
electron paramagnetic resonance oximetry |
white matter |
40.0 |
|
0 |
|
5 scans x 40 seconds |
partial pressure of brain white matter oxygen (CMO:0003626) |
107322 |
3080 |
LEW/Mol |
kidney weight |
standard diet |
Kreutz R, etal., J Hypertens. 2000 Jun;18(6):777-82. doi: 10.1097/00004872-200018060-00017. |
kidney mass |
male |
104 days
| 8 |
|
|
1.1 |
g |
0.03 |
0.08 |
post excision weight measurement |
kidney |
0.0 |
|
0 |
|
|
|
109005 |
3134 |
LEW/Mol |
kidney wet weight to body weight ratio |
standard diet |
Kreutz R, etal., J Hypertens. 2000 Jun;18(6):777-82. doi: 10.1097/00004872-200018060-00017. |
kidney mass |
male |
104 days
| 8 |
|
|
4.04 |
mg/g |
0.03 |
0.08 |
post excision weight measurement |
kidney |
0.0 |
|
0 |
|
|
|
109013 |
3134 |
SHRSP/A3NCrl |
partial pressure of brain white matter oxygen |
standard diet |
Weaver J, etal., J Cereb Blood Flow Metab. 2014 May;34(5):890-6. doi: 10.1038/jcbfm.2014.35. Epub 2014 Feb 19. |
brain oxygen amount |
male |
98 days
| 6 |
|
|
26.0 |
mmHg |
1.2 |
2.94 |
electron paramagnetic resonance oximetry |
white matter |
40.0 |
|
0 |
|
5 scans x 40 seconds |
vascular cognitive impairment |
107316 |
3080 |
LEW/Mol |
body weight |
standard diet |
Kreutz R, etal., J Hypertens. 2000 Jun;18(6):777-82. doi: 10.1097/00004872-200018060-00017. |
body mass |
male |
104 days
| 8 |
|
|
280.0 |
g |
8.5 |
24.04 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
108997 |
3134 |
AA |
liver cholesterol level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
liver cholesterol amount |
male |
448 days
| 8 |
|
|
10.38 |
mg/g |
2.17 |
6.14 |
isolated tissue cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
138343 |
3201 |
Hsd:SD |
liver triglyceride level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
liver triglyceride amount |
male |
448 days
| 9 |
|
|
13.12 |
mg/g |
1.35 |
4.05 |
isolated tissue triglyceride measurement test |
|
0.0 |
|
0 |
|
|
|
138346 |
3201 |
SD-Ldlrem1Sage |
plasma interleukin-6 level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood interleukin-6 amount |
male |
448 days
| 10 |
|
|
140.0 |
pg/ml |
56.0 |
177.09 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
138351 |
3201 |
Hsd:SD |
blood low density lipoprotein particle diameter |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood LDL particle size |
male |
448 days
| 9 |
|
|
22.7 |
nm |
0.1 |
0.3 |
nuclear magnetic resonance spectroscopy |
|
0.0 |
|
0 |
|
|
|
138334 |
3201 |
SD-Ldlrem1 |
plasma creatinine level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood creatinine amount |
male |
448 days
| 8 |
|
|
0.53 |
mg/dl |
0.04 |
0.11 |
automated plasma creatinine analysis |
|
0.0 |
|
0 |
|
|
|
138299 |
3201 |
SD-Ldlrem1Sage |
blood urea nitrogen level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood urea nitrogen amount |
male |
448 days
| 8 |
|
|
14.0 |
mg/dl |
1.0 |
2.83 |
automated blood urea nitrogen analysis |
|
0.0 |
|
0 |
|
|
|
138303 |
3201 |
SD-Ldlrem1Sage |
plasma plasminogen activator inhibitor 1 level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood plasminogen activator inhibitor 1 amount |
male |
448 days
| 8 |
|
|
10.36 |
ng/ml |
0.49 |
1.39 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
138307 |
3201 |
Hsd:SD |
plasma leptin level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood leptin amount |
male |
448 days
| 9 |
|
|
9.83 |
ng/ml |
0.68 |
2.04 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
138314 |
3201 |
SD-Ldlrem1Sage |
plasma free fatty acids level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood free fatty acid amount |
male |
448 days
| 8 |
|
|
0.78 |
mmol/l |
0.12 |
0.34 |
plasma free fatty acid analysis |
|
0.0 |
|
0 |
|
|
|
138323 |
3201 |
Hsd:SD |
plasma high density lipoprotein cholesterol level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood cholesterol amount |
male |
448 days
| 9 |
|
|
69.0 |
mg/dl |
11.0 |
33.0 |
blood cholesterol analysis |
|
0.0 |
|
0 |
|
|
|
138326 |
3201 |
Crl:CD(SD) |
food intake rate |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
168 days
| 19 |
|
|
23.7 |
g/d |
0.48 |
2.1 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85298 |
1604 |
Crl:CD(SD) |
food intake weight to body weight ratio |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
105 days
| 19 |
|
|
5.28 |
g/d/100g |
0.06 |
0.24 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85302 |
1604 |
Crl:CD(SD) |
body weight |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
147 days
| 19 |
|
|
430.0 |
g |
5.96 |
26.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85319 |
1604 |
Crl:CD(SD) |
body weight |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
126 days
| 19 |
|
|
526.0 |
g |
13.31 |
58.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85316 |
1604 |
Crl:CD(SD) |
urine creatine excretion rate |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
urine creatine amount |
male |
106 days
| 19 |
|
|
1.71 |
umol/d |
0.09 |
0.39 |
liquid chromatography-mass spectrometry |
|
0.0 |
|
0 |
|
|
|
85381 |
1604 |
Crl:CD(SD) |
urine creatinine excretion rate |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
urine creatinine amount |
male |
134 days
| 19 |
|
|
16.46 |
mg/d |
0.22 |
0.97 |
liquid chromatography-mass spectrometry |
|
0.0 |
|
0 |
|
|
|
85390 |
1604 |
Crl:CD(SD) |
urine creatinine excretion rate |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
urine creatinine amount |
male |
169 days
| 19 |
|
|
12.28 |
mg/d |
0.58 |
2.51 |
liquid chromatography-mass spectrometry |
|
0.0 |
|
0 |
|
|
|
85393 |
1604 |
Crl:CD(SD) |
body weight |
standard diet and restricted feeding (4 h) then acetaminophen (300 mg/kg) (for 14 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
84 days
| 8 |
|
|
333.0 |
g |
8.13 |
23.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85528 |
1604 |
Crl:CD(SD) |
liver wet weight |
standard diet and restricted feeding (4 h) (for 114 days) then acetaminophen (500 mg/kg) (for 99 days) then fasting (for 20 hours) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
liver mass |
male |
170 days
| 8 |
|
|
12.8 |
g |
0.22 |
0.61 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85559 |
1604 |
WI |
body weight |
controlled in utero environment (for 21 days) and standard diet (100 % of calories) (for 21 days) |
Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10. |
body mass |
male |
68 days
| 21 |
|
|
284.6 |
g |
11.24 |
51.51 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
101053 |
2563 |
SHR/N-cp |
serum glucose level |
standard diet (between 28 and 42 days) then controlled carbohydrate content diet (54 %) (between 140 and 154 days) then controlled hydralazine content drinking water (30 mg/l) (between 84 and 98 days) and hydralazine (50 mg/l) (between 84 and 98 days) and reserpine (4 mg/l) (between 84 and 98 days) |
Velasquez MT, et al., Hypertension. 1997 Nov;30(5):1232-7. |
blood glucose amount |
male |
140 days-168 days |
8 |
|
|
139.76 |
mg/dl |
29.04 |
82.14 |
serum glucose analysis |
|
0.0 |
|
0 |
|
|
|
101510 |
2601 |
SD-Abcc6em2Qlju-/- |
serum calcium to serum phosphate ratio |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood calcium amount |
male |
60 days-180 days |
5 |
|
|
1.53 |
null |
0.12 |
0.27 |
colorimetry |
|
0.0 |
|
0 |
|
|
|
104652 |
2972 |
SD-Abcc6em2Qlju+/+ |
plasma pyrophosphate level |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood pyrophosphate amount |
male |
60 days-180 days |
5 |
|
|
1.08 |
umol/l |
0.17 |
0.38 |
enzymatic method |
|
0.0 |
|
0 |
|
|
|
104654 |
2972 |
SD-Abcc6em2Qlju-/- |
serum phosphate level to plasma pyrophosphate level ratio |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood pyrophosphate amount |
female |
60 days-180 days |
5 |
|
|
1925.5 |
null |
479.2 |
1071.52 |
liquid phase colorimetry |
|
0.0 |
|
0 |
|
|
|
104665 |
2972 |
SD-Abcc6em2Qlju+/- |
serum phosphate level to plasma pyrophosphate level ratio |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood pyrophosphate amount |
female |
60 days-180 days |
5 |
|
|
710.9 |
null |
48.5 |
108.45 |
liquid phase colorimetry |
|
0.0 |
|
0 |
|
|
|
104663 |
2972 |
Crl:WI |
urine total protein excretion rate |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
total urine protein amount |
male |
63 days
| 10 |
|
|
22.8 |
mg/d |
2.47 |
7.81 |
urine protein analysis |
|
0.0 |
|
0 |
|
|
|
104188 |
2927 |
MHS |
creatinine clearance |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
glomerular filtration trait |
male |
63 days
| 10 |
|
|
1.09 |
ml/min |
0.02 |
0.05 |
creatinine analysis by Jaffe reaction with spectrophotometric readout |
|
0.0 |
|
0 |
|
|
|
104181 |
2927 |
MNS |
left kidney wet weight |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
kidney mass |
male |
63 days
| 10 |
|
|
1.05 |
g |
0.02 |
0.07 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
104198 |
2927 |
MNS |
artery tunica media width to artery inner diameter ratio |
standard diet (for 63 days) |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
kidney blood vessel morphology trait |
male |
63 days
| 10 |
|
|
0.55 |
null |
0.06 |
0.2 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
0 |
|
|
|
104214 |
2927 |
MHS |
artery tunica media width to artery inner diameter ratio |
standard diet (for 63 days) |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
kidney blood vessel morphology trait |
male |
63 days
| 10 |
|
|
0.6 |
null |
0.0 |
0.01 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
0 |
|
|
|
104223 |
2927 |
MNS |
artery tunica media width to artery inner diameter ratio |
standard diet (for 270 days) |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
kidney blood vessel morphology trait |
male |
270 days
| 10 |
|
|
0.54 |
null |
0.04 |
0.13 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
0 |
|
|
|
104216 |
2927 |
Crl:CD(SD) |
body weight |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
71 days
| 19 |
|
|
288.0 |
g |
3.67 |
16.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85311 |
1604 |
Crl:CD(SD) |
plasma glucose level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glucose amount |
male |
91 days
| 19 |
|
|
135.0 |
mg/dl |
1.15 |
5.0 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85326 |
1604 |
Crl:CD(SD) |
plasma glucose level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glucose amount |
male |
133 days
| 19 |
|
|
124.0 |
mg/dl |
1.61 |
7.0 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85333 |
1604 |
Crl:CD(SD) |
plasma pyruvate level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood pyruvate amount |
male |
91 days
| 19 |
|
|
0.62 |
mg/dl |
0.01 |
0.05 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85342 |
1604 |
Crl:CD(SD) |
plasma creatinine level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood creatinine amount |
male |
70 days
| 19 |
|
|
0.41 |
mg/dl |
0.0 |
0.02 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85370 |
1604 |
Crl:CD(SD) |
plasma acetaminophen level |
standard diet then acetaminophen (500 mg/kg) (for 99 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood acetaminophen amount |
male |
170 days
| 8 |
|
|
118.1 |
ug/ml |
6.43 |
18.2 |
high-performance liquid chromatography |
|
0.0 |
acetaminophen dosing |
240 |
min |
|
4 hr after dosing |
85579 |
1604 |
Crl:CD(SD) |
plasma glutamate dehydrogenase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glutamate dehydrogenase amount |
male |
105 days
| 19 |
|
|
14.7 |
U/l |
0.64 |
2.8 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85448 |
1604 |
Crl:CD(SD) |
food intake rate |
standard diet then acetaminophen (500 mg/kg) (for 35 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
105 days
| 8 |
|
|
25.7 |
g/d |
0.28 |
0.8 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85466 |
1604 |
Crl:CD(SD) |
food intake rate |
standard diet and restricted feeding (4 h) then acetaminophen (500 mg/kg) (for 98 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
168 days
| 8 |
|
|
16.6 |
g/d |
0.95 |
2.7 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85487 |
1604 |
Crl:CD(SD) |
body weight |
standard diet and restricted feeding (4 h) then acetaminophen (300 mg/kg) (for 98 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
168 days
| 8 |
|
|
447.0 |
g |
16.62 |
47.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85552 |
1604 |
Crl:CD(SD) |
food intake rate |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
126 days
| 19 |
|
|
20.1 |
g/d |
0.5 |
2.2 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85295 |
1604 |
Crl:CD(SD) |
food intake rate |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
168 days
| 19 |
|
|
17.2 |
g/d |
0.83 |
3.6 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85299 |
1604 |
Crl:CD(SD) |
food intake weight to body weight ratio |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
105 days
| 19 |
|
|
5.36 |
g/d/100g |
0.15 |
0.65 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85303 |
1604 |
Crl:CD(SD) |
food intake weight to body weight ratio |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
147 days
| 19 |
|
|
4.44 |
g/d/100g |
0.06 |
0.28 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85306 |
1604 |
Crl:CD(SD) |
plasma creatinine level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood creatinine amount |
male |
105 days
| 19 |
|
|
0.41 |
mg/dl |
0.01 |
0.03 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85373 |
1604 |
Crl:CD(SD) |
urine creatinine excretion rate |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
urine creatinine amount |
male |
106 days
| 19 |
|
|
11.98 |
mg/d |
0.42 |
1.84 |
liquid chromatography-mass spectrometry |
|
0.0 |
|
0 |
|
|
|
85389 |
1604 |
Crl:CD(SD) |
urine creatinine excretion rate |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
urine creatinine amount |
male |
106 days
| 19 |
|
|
13.78 |
mg/d |
0.28 |
1.21 |
liquid chromatography-mass spectrometry |
|
0.0 |
|
0 |
|
|
|
85388 |
1604 |
Crl:CD(SD) |
plasma aspartate aminotransferase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood aspartate transaminase amount |
male |
78 days
| 19 |
|
|
61.0 |
U/l |
2.09 |
9.1 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85412 |
1604 |
Crl:CD(SD) |
plasma aspartate aminotransferase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood aspartate transaminase amount |
male |
78 days
| 19 |
|
|
59.1 |
U/l |
1.28 |
5.6 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85413 |
1604 |
Crl:CD(SD) |
plasma aspartate aminotransferase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood aspartate transaminase amount |
male |
70 days
| 19 |
|
|
61.8 |
U/l |
1.26 |
5.5 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85411 |
1604 |
Crl:CD(SD) |
plasma aspartate aminotransferase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood aspartate transaminase amount |
male |
105 days
| 19 |
|
|
58.0 |
U/l |
2.39 |
10.4 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85416 |
1604 |
Crl:CD(SD) |
plasma alanine aminotransferase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood alanine transaminase amount |
male |
70 days
| 19 |
|
|
32.5 |
U/l |
0.71 |
3.1 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85426 |
1604 |
Crl:CD(SD) |
food intake rate |
standard diet then acetaminophen (500 mg/kg) (for 14 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
84 days
| 8 |
|
|
24.7 |
g/d |
0.46 |
1.3 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85460 |
1604 |
Crl:CD(SD) |
food intake weight to body weight ratio |
standard diet then acetaminophen (300 mg/kg) (for 14 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
84 days
| 8 |
|
|
5.74 |
g/d/100g |
0.1 |
0.29 |
unspecified method |
|
0.0 |
|
0 |
|
|
on days 11-14 |
85489 |
1604 |
Crl:CD(SD) |
food intake weight to body weight ratio |
standard diet then acetaminophen (300 mg/kg) (for 56 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
126 days
| 8 |
|
|
4.7 |
g/d/100g |
0.06 |
0.17 |
unspecified method |
|
0.0 |
|
0 |
|
|
on days 53-56 |
85501 |
1604 |
Crl:CD(SD) |
food intake weight to body weight ratio |
standard diet and restricted feeding (4 h) then acetaminophen (300 mg/kg) (for 56 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
126 days
| 8 |
|
|
4.38 |
g/d/100g |
0.31 |
0.87 |
unspecified method |
|
0.0 |
|
0 |
|
|
on days 53-56 |
85504 |
1604 |
Crl:CD(SD) |
food intake weight to body weight ratio |
standard diet then acetaminophen (500 mg/kg) (for 77 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
147 days
| 8 |
|
|
4.49 |
g/d/100g |
0.08 |
0.23 |
unspecified method |
|
0.0 |
|
0 |
|
|
on days 74-77 |
85508 |
1604 |
Crl:CD(SD) |
food intake weight to body weight ratio |
standard diet and restricted feeding (4 h) then acetaminophen (500 mg/kg) (for 56 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
126 days
| 8 |
|
|
4.23 |
g/d/100g |
0.27 |
0.77 |
unspecified method |
|
0.0 |
|
0 |
|
|
on days 53-56 |
85505 |
1604 |
Crl:CD(SD) |
body weight |
standard diet then acetaminophen (300 mg/kg) (for 1 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
71 days
| 8 |
|
|
371.0 |
g |
5.66 |
16.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85519 |
1604 |
Crl:CD(SD) |
body weight |
standard diet and restricted feeding (4 h) then acetaminophen (500 mg/kg) (for 56 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
126 days
| 8 |
|
|
400.0 |
g |
7.78 |
22.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85541 |
1604 |
Crl:CD(SD) |
body weight |
standard diet and restricted feeding (4 h) then acetaminophen (500 mg/kg) (for 14 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
84 days
| 8 |
|
|
321.0 |
g |
7.78 |
22.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85529 |
1604 |
Crl:CD(SD) |
body weight |
standard diet and restricted feeding (4 h) then acetaminophen (500 mg/kg) (for 35 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
105 days
| 8 |
|
|
365.0 |
g |
6.36 |
18.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85535 |
1604 |
Crl:CD(SD) |
body weight |
standard diet then acetaminophen (500 mg/kg) (for 98 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
168 days
| 8 |
|
|
564.0 |
g |
15.2 |
43.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85550 |
1604 |
Crl:CD(SD) |
plasma pyruvate level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood pyruvate amount |
male |
133 days
| 19 |
|
|
0.91 |
mg/dl |
0.1 |
0.43 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85349 |
1604 |
Crl:CD(SD) |
plasma pyruvate level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood pyruvate amount |
male |
133 days
| 19 |
|
|
0.55 |
mg/dl |
0.03 |
0.12 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85348 |
1604 |
Crl:CD(SD) |
food intake rate |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
147 days
| 19 |
|
|
23.9 |
g/d |
0.39 |
1.7 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85296 |
1604 |
Crl:CD(SD) |
body weight |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
84 days
| 19 |
|
|
328.0 |
g |
4.82 |
21.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85313 |
1604 |
Crl:CD(SD) |
plasma glucose level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glucose amount |
male |
70 days
| 19 |
|
|
117.0 |
mg/dl |
1.84 |
8.0 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85323 |
1604 |
Crl:CD(SD) |
plasma glucose level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glucose amount |
male |
119 days
| 19 |
|
|
129.0 |
mg/dl |
2.29 |
10.0 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85330 |
1604 |
Crl:CD(SD) |
plasma glucose level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glucose amount |
male |
168 days
| 19 |
|
|
131.0 |
mg/dl |
1.61 |
7.0 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85336 |
1604 |
Crl:CD(SD) |
plasma lactate level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood lactate amount |
male |
168 days
| 19 |
|
|
18.9 |
mg/dl |
1.67 |
7.3 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85369 |
1604 |
Crl:CD(SD) |
plasma aspartate aminotransferase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood aspartate transaminase amount |
male |
119 days
| 19 |
|
|
58.8 |
U/l |
1.54 |
6.7 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85419 |
1604 |
Crl:CD(SD) |
plasma alanine aminotransferase activity level |
standard diet and restricted feeding (4 h) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood alanine transaminase amount |
male |
147 days
| 19 |
|
|
34.4 |
U/l |
1.31 |
5.7 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85439 |
1604 |
Crl:CD(SD) |
plasma glutamate dehydrogenase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glutamate dehydrogenase amount |
male |
70 days
| 19 |
|
|
14.3 |
U/l |
0.55 |
2.4 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85442 |
1604 |
Crl:CD(SD) |
plasma glutamate dehydrogenase activity level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood glutamate dehydrogenase amount |
male |
119 days
| 19 |
|
|
14.8 |
U/l |
0.89 |
3.9 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85450 |
1604 |
Crl:CD(SD) |
liver reduced glutathione level to liver weight ratio |
standard diet then acetaminophen (300 mg/kg) (for 99 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
liver glutathione amount |
male |
170 days
| 8 |
|
|
9.16 |
umol/g |
0.18 |
0.5 |
reduced glutathione/oxidized glutathione enzyme recycling assay |
|
0.0 |
|
0 |
|
enzyme recycling method |
reduced liver glutathione level to liver weight ratio |
85567 |
1604 |
Crl:CD(SD) |
food intake rate |
standard diet and restricted feeding (4 h) then acetaminophen (300 mg/kg) (for 56 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
eating behavior trait |
male |
126 days
| 8 |
|
|
22.1 |
g/d |
0.71 |
2.0 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
85474 |
1604 |
Crl:CD(SD) |
body weight |
standard diet and restricted feeding (4 h) then acetaminophen (300 mg/kg) (for 77 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
147 days
| 8 |
|
|
432.0 |
g |
17.32 |
49.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85546 |
1604 |
Crl:CD(SD) |
liver oxidized glutathione level to liver weight ratio |
standard diet and restricted feeding (4 h) (for 114 days) then acetaminophen (500 mg/kg) (for 99 days) then fasting (for 20 hours) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
liver glutathione amount |
male |
170 days
| 8 |
|
|
0.14 |
umol/g |
0.0 |
0.01 |
reduced glutathione/oxidized glutathione enzyme recycling assay |
|
0.0 |
|
0 |
|
enzyme recycling method |
|
85577 |
1604 |
GK/Jcl |
blood glucose level |
standard diet |
Radosinska J, et al., Physiol Res. 2015;64(6):795-806. Epub 2015 Oct 8. |
blood glucose amount |
male |
84 days
| 8 |
|
|
478.26 |
mg/dl |
23.74 |
67.14 |
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
103073 |
2785 |
HTG |
liver cholesterol level |
standard diet (for 20 days) |
Orolin J, et al., Food Chem Toxicol. 2009 Oct;47(10):2624-30. doi: 10.1016/j.fct.2009.07.022. Epub 2009 Jul 25. |
liver cholesterol amount |
male |
0 days
| 7 |
|
|
3.71 |
mg/g |
0.13 |
0.35 |
enzymatic cholesterol assay |
|
0.0 |
|
0 |
|
|
|
98896 |
2178 |
WKY |
plasma total cholesterol level |
standard diet (for 20 days) |
Orolin J, et al., Food Chem Toxicol. 2009 Oct;47(10):2624-30. doi: 10.1016/j.fct.2009.07.022. Epub 2009 Jul 25. |
blood cholesterol amount |
male |
0 days
| 7 |
|
|
61.39 |
mg/dl |
4.25 |
11.24 |
enzymatic cholesterol assay |
|
0.0 |
|
0 |
|
|
|
98902 |
2178 |
WKY |
plasma triglyceride level |
standard diet (for 20 days) |
Orolin J, et al., Food Chem Toxicol. 2009 Oct;47(10):2624-30. doi: 10.1016/j.fct.2009.07.022. Epub 2009 Jul 25. |
blood triglyceride amount |
male |
0 days
| 7 |
|
|
0.48 |
mmol/l |
0.02 |
0.05 |
enzymatic triglyceride assay |
|
0.0 |
|
0 |
|
|
|
98918 |
2178 |
HTG |
plasma triglyceride level |
standard diet (for 20 days) |
Orolin J, et al., Food Chem Toxicol. 2009 Oct;47(10):2624-30. doi: 10.1016/j.fct.2009.07.022. Epub 2009 Jul 25. |
blood triglyceride amount |
male |
0 days
| 7 |
|
|
0.83 |
mmol/l |
0.07 |
0.19 |
enzymatic triglyceride assay |
|
0.0 |
|
0 |
|
|
|
98920 |
2178 |
SHR/N-cp |
serum glucose level |
standard diet (between 28 and 42 days) then controlled carbohydrate content diet (54 %) (between 42 and 56 days) |
Velasquez MT, et al., Hypertension. 1997 Nov;30(5):1232-7. |
blood glucose amount |
male |
70 days-98 days |
8 |
|
|
185.13 |
mg/dl |
32.67 |
92.4 |
serum glucose analysis |
|
0.0 |
|
0 |
|
|
|
101499 |
2601 |
SHR/N-cp |
serum glucose level |
standard diet (between 28 and 42 days) then controlled carbohydrate content diet (54 %) (between 42 and 56 days) then perindopril (0.25-0.5 mg/kg/d) |
Velasquez MT, et al., Hypertension. 1997 Nov;30(5):1232-7. |
blood glucose amount |
male |
70 days-98 days |
8 |
|
|
154.28 |
mg/dl |
19.97 |
56.47 |
serum glucose analysis |
|
0.0 |
|
0 |
|
|
|
101500 |
2601 |
WI |
serum potassium level |
controlled in utero environment (for 21 days) and standard diet (100 % of calories) (for 21 days) |
Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10. |
blood potassium amount |
male |
102 days
| 6 |
|
|
3.5 |
mmol/l |
0.23 |
0.56 |
automated serum potassium test |
|
0.0 |
|
0 |
|
|
|
101059 |
2563 |
SHR/N-cp |
serum glucose level |
standard diet (between 28 and 42 days) then controlled carbohydrate content diet (54 %) (between 42 and 56 days) then controlled hydralazine content drinking water (30 mg/l) and hydralazine (50 mg/l) and reserpine (4 mg/l) |
Velasquez MT, et al., Hypertension. 1997 Nov;30(5):1232-7. |
blood glucose amount |
male |
70 days-98 days |
8 |
|
|
139.76 |
mg/dl |
14.52 |
41.07 |
serum glucose analysis |
|
0.0 |
|
0 |
|
|
|
101501 |
2601 |
SHR/N-cp |
both kidneys wet weight to body weight ratio |
standard diet (between 28 and 42 days) then controlled carbohydrate content diet (54 %) (between 140 and 154 days) |
Velasquez MT, et al., Hypertension. 1997 Nov;30(5):1232-7. |
kidney mass |
male |
168 days-196 days |
8 |
|
|
1.88 |
g/kg |
0.1 |
0.28 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
101523 |
2601 |
SHR/N-cp |
plasma renin activity level |
standard diet (between 28 and 42 days) then controlled carbohydrate content diet (54 %) (between 140 and 154 days) then perindopril (0.25-0.5 mg/kg/d) (between 84 and 98 days) |
Velasquez MT, et al., Hypertension. 1997 Nov;30(5):1232-7. |
renin activity |
male |
168 days-196 days |
8 |
|
|
52.0 |
ng/ml/h |
8.0 |
22.63 |
radioimmunoassay |
|
0.0 |
|
0 |
|
|
|
101533 |
2601 |
WI |
creatinine clearance to body weight ratio |
controlled in utero environment (for 21 days) and standard diet (100 % of calories) (for 21 days) |
Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10. |
glomerular filtration trait |
male |
102 days
| 6 |
|
|
0.54 |
ml/min/100g |
0.06 |
0.13 |
serum creatinine analysis |
|
0.0 |
|
0 |
|
|
|
101065 |
2563 |
WI |
urine potassium excretion rate |
controlled in utero environment (for 21 days) and standard diet (100 % of calories) (for 21 days) |
Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10. |
urine potassium amount |
male |
102 days
| 6 |
|
|
83.0 |
mEq/d |
0.5 |
1.22 |
urine potassium analysis |
|
0.0 |
|
0 |
|
|
|
101063 |
2563 |
SD-Lepem1Sage-/- |
blood insulin level |
fasting (for 12 hours) then standard diet (for 1 hours) |
D'souza AM, et al., Endocrinology. 2014 Apr;155(4):1268-79. doi: 10.1210/en.2013-1523. Epub 2014 Jan 27. |
blood insulin amount |
male |
91 days
| 6 |
|
|
2198.55 |
mU/l |
95.59 |
234.14 |
blood insulin analysis |
|
0.0 |
|
0 |
|
|
|
104477 |
2949 |
SD-Abcc6em2Qlju+/- |
serum calcium level |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood calcium amount |
male |
60 days-180 days |
5 |
|
|
10.0 |
mg/dl |
0.3 |
0.67 |
colorimetry |
|
0.0 |
|
0 |
|
|
|
104638 |
2972 |
SD-Abcc6em2Qlju+/- |
serum phosphate level |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood phosphate amount |
male |
60 days-180 days |
5 |
|
|
7.1 |
mg/dl |
0.6 |
1.34 |
liquid phase colorimetry |
|
0.0 |
|
0 |
|
|
|
104644 |
2972 |
SD-Abcc6em2Qlju-/- |
serum phosphate level |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood phosphate amount |
female |
60 days-180 days |
5 |
|
|
5.9 |
mg/dl |
0.2 |
0.45 |
liquid phase colorimetry |
|
0.0 |
|
0 |
|
|
|
104647 |
2972 |
SD-Abcc6em2Qlju+/- |
serum calcium to serum phosphate ratio |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood calcium amount |
female |
60 days-180 days |
5 |
|
|
1.76 |
null |
0.05 |
0.11 |
colorimetry |
|
0.0 |
|
0 |
|
|
|
104651 |
2972 |
SD-Abcc6em2Qlju-/- |
plasma pyrophosphate level |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood pyrophosphate amount |
male |
60 days-180 days |
5 |
|
|
0.29 |
umol/l |
0.07 |
0.16 |
enzymatic method |
|
0.0 |
|
0 |
|
|
|
104658 |
2972 |
MNS |
serum creatinine level |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
blood creatinine amount |
male |
270 days
| 10 |
|
|
0.52 |
mg/dl |
0.01 |
0.02 |
creatinine analysis by Jaffe reaction with spectrophotometric readout |
|
0.0 |
|
0 |
|
|
|
104177 |
2927 |
MNS |
urine total protein excretion rate |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
total urine protein amount |
male |
63 days
| 10 |
|
|
25.04 |
mg/d |
1.77 |
5.6 |
urine protein analysis |
|
0.0 |
|
0 |
|
|
|
104186 |
2927 |
MNS |
body weight |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
body mass |
male |
270 days
| 10 |
|
|
565.2 |
g |
8.06 |
25.5 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
104195 |
2927 |
MNS |
left kidney wet weight to body weight ratio |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
kidney mass |
male |
270 days
| 10 |
|
|
3.9 |
mg/g |
0.03 |
0.1 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
104207 |
2927 |
MNS |
artery inner diameter |
standard diet (for 270 days) |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
kidney blood vessel morphology trait |
male |
270 days
| 10 |
|
|
18.1 |
um |
1.08 |
3.4 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
0 |
|
|
|
104228 |
2927 |
MHS |
artery lumen to artery total diameter ratio |
standard diet (for 270 days) |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
kidney blood vessel morphology trait |
male |
270 days
| 10 |
|
|
36.7 |
% |
0.6 |
1.9 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
0 |
|
|
|
104233 |
2927 |
MWF/Ztm |
urine total protein excretion rate |
standard diet |
Remuzzi A, etal., Kidney Int. 1988 Oct;34(4):481-6. doi: 10.1038/ki.1988.206. |
urine protein amount |
male |
147 days
| 5 |
|
|
291.0 |
mg/d |
22.81 |
51.0 |
Bradford protein assay |
|
0.0 |
|
0 |
|
|
|
109201 |
3138 |
MWF/Ztm |
podocyte slit width |
standard diet |
Iordache BE, etal., J Am Soc Nephrol. 1994 Dec;5(6):1378-84. |
podocyte morphology trait |
male |
131 days
| 6 |
|
|
39.0 |
nm |
1.63 |
4.0 |
ex vivo electron microscopy with digital image analysis |
|
0.0 |
|
0 |
|
|
|
109185 |
3136 |
MWF/Ztm |
total filtering surface area per glomerulus |
standard diet |
Iordache BE, etal., J Am Soc Nephrol. 1994 Dec;5(6):1378-84. |
kidney glomerulus morphology trait |
male |
131 days
| 6 |
NA |
|
0.28 |
mm2 |
0.02 |
0.04 |
ex vivo electron microscopy with digital image analysis |
renal glomerulus |
0.0 |
|
0 |
|
|
|
109163 |
3136 |
MWF/Ztm |
body weight |
standard diet |
Remuzzi A, etal., Kidney Int. 1988 Oct;34(4):481-6. doi: 10.1038/ki.1988.206. |
body mass |
female |
126 days-153 days |
8 |
|
|
218.0 |
g |
3.89 |
11.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
109198 |
3138 |
MWF/Ztm |
kidney sclerotic glomeruli count to total glomeruli count ratio |
standard diet |
Remuzzi A, etal., Am J Kidney Dis. 1999 Oct;34(4):626-32. doi: 10.1016/S0272-6386(99)70385-9. |
kidney glomerulus integrity trait |
male |
210 days
| 10 |
|
median |
18.6 |
% |
|
|
ex vivo light microscopy with histochemistry |
left kidney |
0.0 |
|
0 |
|
|
|
109986 |
3162 |
MWF/Fub |
kidney weight |
standard diet |
Kreutz R, etal., J Hypertens. 2000 Jun;18(6):777-82. doi: 10.1097/00004872-200018060-00017. |
kidney mass |
female |
104 days
| 8 |
|
|
0.54 |
g |
0.03 |
0.08 |
post excision weight measurement |
kidney |
0.0 |
|
0 |
|
|
|
109008 |
3134 |
SHRSP/A3NCrl |
partial pressure of brain white matter oxygen |
standard diet |
Weaver J, etal., J Cereb Blood Flow Metab. 2014 May;34(5):890-6. doi: 10.1038/jcbfm.2014.35. Epub 2014 Feb 19. |
brain oxygen amount |
male |
105 days
| 6 |
|
|
25.8 |
mmHg |
1.2 |
2.94 |
electron paramagnetic resonance oximetry |
white matter |
40.0 |
|
0 |
|
5 scans x 40 seconds |
vascular cognitive impairment |
107317 |
3080 |
SD-Ldlrem1Sage |
plasma total protein level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood total protein amount |
male |
448 days
| 8 |
|
|
68.2 |
mg/ml |
2.5 |
7.07 |
automated plasma total protein analysis |
|
0.0 |
|
0 |
|
|
|
138283 |
3201 |
SD-Ldlrem1Sage |
plasma alanine aminotransferase activity level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood alanine transaminase amount |
male |
448 days
| 8 |
|
|
39.0 |
U/l |
1.0 |
2.83 |
automated plasma alanine aminotransferase activity assay |
|
0.0 |
|
0 |
|
|
|
138286 |
3201 |
Hsd:SD |
plasma creatine kinase activity level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood creatine kinase amount |
male |
448 days
| 9 |
|
|
670.0 |
U/l |
93.0 |
279.0 |
automated plasma creatine kinase activity assay |
|
0.0 |
|
0 |
|
|
CK |
138293 |
3201 |
Hsd:SD |
blood urea nitrogen level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood urea nitrogen amount |
male |
448 days
| 9 |
|
|
21.0 |
mg/dl |
2.0 |
6.0 |
automated blood urea nitrogen analysis |
|
0.0 |
|
0 |
|
|
|
138302 |
3201 |
Hsd:SD |
blood fibrinogen level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
fibrin formation trait |
male |
448 days
| 9 |
|
|
3.14 |
mg/ml |
0.13 |
0.39 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
138310 |
3201 |
Crl:CD(SD) |
plasma lactate level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood lactate amount |
male |
133 days
| 19 |
|
|
17.4 |
mg/dl |
0.85 |
3.7 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85364 |
1604 |
Crl:CD(SD) |
plasma lactate level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood lactate amount |
male |
70 days
| 19 |
|
|
20.5 |
mg/dl |
1.81 |
7.9 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85354 |
1604 |
SHR/N-cp |
serum glucose level |
standard diet (between 28 and 42 days) then controlled carbohydrate content diet (54 %) (between 84 and 98 days) |
Velasquez MT, et al., Hypertension. 1997 Nov;30(5):1232-7. |
blood glucose amount |
male |
112 days-140 days |
8 |
|
|
150.65 |
mg/dl |
23.6 |
66.74 |
serum glucose analysis |
|
0.0 |
|
0 |
|
|
|
101502 |
2601 |
SHR/N-cp |
serum glucose level |
standard diet (between 28 and 42 days) then controlled carbohydrate content diet (54 %) (between 112 and 126 days) then controlled hydralazine content drinking water (30 mg/l) (between 56 and 70 days) and hydralazine (50 mg/l) (between 56 and 70 days) and reserpine (4 mg/l) (between 56 and 70 days) |
Velasquez MT, et al., Hypertension. 1997 Nov;30(5):1232-7. |
blood glucose amount |
male |
140 days-168 days |
8 |
|
|
157.91 |
mg/dl |
34.49 |
97.54 |
serum glucose analysis |
|
0.0 |
|
0 |
|
|
|
101507 |
2601 |
SHR/N-cp |
serum glucose level |
standard diet (between 28 and 42 days) then controlled carbohydrate content diet (54 %) (between 84 and 98 days) then controlled hydralazine content drinking water (30 mg/l) (between 28 and 42 days) and hydralazine (50 mg/l) (between 28 and 42 days) and reserpine (4 mg/l) (between 28 and 42 days) |
Velasquez MT, et al., Hypertension. 1997 Nov;30(5):1232-7. |
blood glucose amount |
male |
112 days-140 days |
8 |
|
|
137.94 |
mg/dl |
30.86 |
87.27 |
serum glucose analysis |
|
0.0 |
|
0 |
|
|
|
101504 |
2601 |
WI |
plasma triglyceride level |
controlled in utero environment (for 21 days) and standard diet (50 % of calories) (for 21 days) |
Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10. |
blood triglyceride amount |
male |
102 days
| 6 |
|
|
0.52 |
mmol/l |
0.05 |
0.13 |
plasma triglyceride analysis |
|
0.0 |
|
0 |
|
|
|
101070 |
2563 |
WI |
glucose disappearance constant |
controlled in utero environment (for 21 days) and standard diet (100 % of calories) (for 21 days) |
Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10. |
blood glucose amount |
male |
102 days
| 6 |
|
|
2.86 |
null |
0.35 |
0.86 |
serum glucose analysis |
|
0.0 |
|
0 |
|
|
|
101073 |
2563 |
Crl:CD(SD) |
body weight |
standard diet then acetaminophen (300 mg/kg) (for 35 days) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
body mass |
male |
105 days
| 8 |
|
|
477.0 |
g |
7.42 |
21.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
85531 |
1604 |
Crl:CD(SD) |
liver oxidized glutathione level to liver weight ratio |
standard diet and restricted feeding (4 h) (for 114 days) then acetaminophen (300 mg/kg) (for 99 days) then fasting (for 20 hours) |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
liver glutathione amount |
male |
170 days
| 8 |
|
|
0.16 |
umol/g |
0.01 |
0.03 |
reduced glutathione/oxidized glutathione enzyme recycling assay |
|
0.0 |
|
0 |
|
enzyme recycling method |
|
85576 |
1604 |
SD-Abcc6em2Qlju+/+ |
serum calcium level |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood calcium amount |
female |
60 days-180 days |
5 |
|
|
9.7 |
mg/dl |
0.2 |
0.45 |
colorimetry |
|
0.0 |
|
0 |
|
|
|
104637 |
2972 |
SD-Abcc6em2Qlju-/- |
serum calcium level |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood calcium amount |
male |
60 days-180 days |
5 |
|
|
10.5 |
mg/dl |
0.2 |
0.45 |
colorimetry |
|
0.0 |
|
0 |
|
|
|
104640 |
2972 |
SD-Abcc6em2Qlju+/+ |
serum phosphate level to plasma pyrophosphate level ratio |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood pyrophosphate amount |
male |
60 days-180 days |
5 |
|
|
455.3 |
null |
54.2 |
121.19 |
liquid phase colorimetry |
|
0.0 |
|
0 |
|
|
|
104660 |
2972 |
Crl:WI |
timed urine volume |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
urine output |
male |
63 days
| 10 |
|
|
15.6 |
ml/d |
2.25 |
7.13 |
urine volume measurement method |
|
0.0 |
|
0 |
|
|
|
104173 |
2927 |
Crl:WI |
serum creatinine level |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
blood creatinine amount |
male |
63 days
| 10 |
|
|
0.32 |
mg/dl |
0.0 |
0.01 |
creatinine analysis by Jaffe reaction with spectrophotometric readout |
|
0.0 |
|
0 |
|
|
|
104176 |
2927 |
MHS |
serum creatinine level |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
blood creatinine amount |
male |
270 days
| 10 |
|
|
0.38 |
mg/dl |
0.01 |
0.02 |
creatinine analysis by Jaffe reaction with spectrophotometric readout |
|
0.0 |
|
0 |
|
|
|
104178 |
2927 |
MNS |
left kidney wet weight |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
kidney mass |
male |
270 days
| 10 |
|
|
2.18 |
g |
0.04 |
0.13 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
104201 |
2927 |
MNS |
left kidney wet weight to body weight ratio |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
kidney mass |
male |
63 days
| 10 |
|
|
3.9 |
mg/g |
0.06 |
0.2 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
104204 |
2927 |
Crl:WI |
left kidney wet weight to body weight ratio |
standard diet |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
kidney mass |
male |
63 days
| 10 |
|
|
4.2 |
mg/g |
0.09 |
0.3 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
104206 |
2927 |
MHS |
artery inner diameter |
standard diet (for 270 days) |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
kidney blood vessel morphology trait |
male |
270 days
| 10 |
|
|
12.9 |
um |
0.38 |
1.2 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
0 |
|
|
|
104229 |
2927 |
MNS |
artery inner diameter |
standard diet (for 63 days) |
Menini S, et al., J Hypertens. 2004 Nov;22(11):2185-92. |
kidney blood vessel morphology trait |
male |
63 days
| 10 |
|
|
18.5 |
um |
1.49 |
4.7 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
0 |
|
|
|
104226 |
2927 |
Crl:CD(SD) |
plasma lactate level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood lactate amount |
male |
168 days
| 19 |
|
|
15.1 |
mg/dl |
0.46 |
2.0 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85368 |
1604 |
Crl:CD(SD) |
plasma creatinine level |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
blood creatinine amount |
male |
133 days
| 19 |
|
|
0.37 |
mg/dl |
0.0 |
0.02 |
automated blood analysis |
|
0.0 |
|
0 |
|
TBA-120FR, Toshiba corporation, Japan |
|
85374 |
1604 |
Crl:CD(SD) |
urine creatinine excretion rate |
standard diet |
Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. |
urine creatinine amount |
male |
70 days
| 19 |
|
|
9.72 |
mg/d |
0.23 |
1.0 |
liquid chromatography-mass spectrometry |
|
0.0 |
|
0 |
|
|
|
85386 |
1604 |
WKY |
plasma low density lipoprotein cholesterol level |
standard diet (for 20 days) |
Orolin J, et al., Food Chem Toxicol. 2009 Oct;47(10):2624-30. doi: 10.1016/j.fct.2009.07.022. Epub 2009 Jul 25. |
blood LDL cholesterol amount |
male |
0 days
| 7 |
|
|
10.04 |
mg/dl |
1.16 |
3.06 |
enzymatic cholesterol assay |
|
0.0 |
|
0 |
|
|
|
98910 |
2178 |
SD-Abcc6em2Qlju+/- |
serum phosphate level to plasma pyrophosphate level ratio |
standard diet |
Li Q, et al., J Invest Dermatol. 2017 May;137(5):1025-1032. doi: 10.1016/j.jid.2016.11.042. Epub 2017 Jan 19. |
blood pyrophosphate amount |
male |
60 days-180 days |
5 |
|
|
820.6 |
null |
144.1 |
322.22 |
liquid phase colorimetry |
|
0.0 |
|
0 |
|
|
|
104662 |
2972 |